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ABSTRACT
Particle-Induced Pulmonary Inflammation and Fibrosis: Role of inflammatory
mediators in the initiation and progression of occupational lung disease
Patti C. Zeidler
Pulmonary fibrosis due to acute or chronic occupational exposures is the leading
cause of work-related illness in the U.S. according to the 2002 report by the American
Lung Association. Asbestosis and silicosis are well described lung diseases that result
from asbestos fiber or crystalline silica inhalation, respectively. This study investigated
the underlying lung inflammatory and fibrotic mechanisms involved in the response
caused by exposure to crystalline silica (α-quartz) or JM-100 glass, chrysotile asbestos,
and ceramic fibers. Two topics were investigated: 1.) The role of fiber dimension and
chemical composition in the response of alveolar macrophages (AMs) 2.) The role of
inducible nitric oxide synthase (iNOS) derived nitric oxide (NO) in silica-induced lung
inflammation and fibrosis. The second topic examined silica-induced responses as well
as an experimental model of lung damage and inflammation, lipopolysaccharide (LPS) +
interferon-γ (IFN-γ) exposure. Therefore, this investigation involves a common theme
that includes lung damage, inflammation, and resulting fibrosis.
The first topic revealed fiber length and chemical composition are important
factors in fiber-induced cellular effects. Cellular effects of length-classified glass fibers
(7 and 17 µm) or three types of fibers (glass, chrysotile, or ceramic) of similar lengths
were monitored in primary rat AMs in vitro. Longer (17 µm) fibers that were unable to
be fully engulfed by AMs (i.e. frustrated phagocytosis) caused greater mediator
production than short (7 µm) fibers. Fibers of the same length but different chemical
compositions also resulted in differential mediator production and cytotoxicity; however,
the contribution of length to fiber potency appears greater than chemistry. Human AMs
were also used to determine the effects of length-classified JM-100 glass fibers
(8,10,16,20 µm) due to the fact that human AMs are larger in comparison to the rat,
approximately 18 µm as compared to 13 µm, respectively. In human AMs, all fiber
length fractions tested were completely engulfed and exhibited equal cytotoxicity in the
same dose-dependent fashion. Therefore, the data indicate that, because human AMs
are larger than rat AMs, they are able to phagocytize longer fibers and the absence of
frustrated phagocytosis results in lower fiber toxicity in human AMs. These differences
in the AM response to long fibers between human and rat phagocytes are pertinent to
the assessment of fiber-induced health effects.
The role of iNOS derived NO in pulmonary disease states remains unresolved
with both anti-inflammatory [scavenging radicals and inhibiting nuclear factor-κB (NFκB) activation] and pro-inflammatory (forming highly reactive peroxynitrite and
augmenting NF-κB activation by inflammatory agents) actions reported. Therefore, a
series of studies have been initiated to determine whether deletion of the iNOS gene in
the C57BL/6J mouse alters the pulmonary response to silica or LPS + IFN-γ. Data show
that increased inflammation and damage due to acute exposure to LPS + IFN-γ was

evident in the iNOS knockout (KO) compared to wild type (WT) mice. On the other
hand, attenuation of sub-chronic silica-induced lung effects was observed in the iNOS
KO mice. The differential responses of the iNOS KO and WT mice to various stimuli
could be attributed to factors related to the complex nature of the signaling pathways for
toll-like versus scavenger receptors and/or the inflammatory and immune response to
these stimuli.
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LITERATURE REVIEW
Interstitial Lung Disease
Interstitial lung disease (ILD), or pulmonary fibrosis, is characterized by alveolar
thickening, sustained activation of pulmonary cells, and abnormal extracellular matrix
(ECM) protein, i.e. collagen, deposition by interstitial lung fibroblasts (Crystal et
al.,1984;Rom et al.,1991). Thickening of the alveolar septa due to ECM protein
deposition in the lower respiratory tract decreases lung elasticity resulting in chest
stiffness and shallow, labored breathing (Raghu et al.,1985). Lung function in patients
with pulmonary fibrosis may be altered due to the increased collagen deposition leading
to decreases in static lung volumes characteristic of restrictive lung diseases (Collard &
King,2003). Thickening of alveolar septa results in decreased oxygen transfer to the
blood which makes supplemental oxygen a possible necessity for the patient (Collard &
King,2003).
Pulmonary fibrosis includes more than 130 disorders of the lung and comprises
15% of cases encountered by pulmonologists (National Jewish Medical and Research
Center). Pulmonary fibrosis can result from occupational or environmental dust, gas
and/or fume exposure, connective tissue disease, infection, or use of certain
medications. However, approximately two-thirds of the cases of pulmonary fibrosis are
of unknown etiology and are diagnosed as “idiopathic” pulmonary fibrosis or IPF,
according to the National Jewish Medical and Research Center.
Certain therapeutic drugs can lead to the progression of pulmonary fibrosis and
of the known causes of pulmonary fibrosis; bleomycin-induced pneumonitis (BIP) is an
area of considerable research. Bleomycin is a cytotoxic agent commonly used for
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treatment of tumors, such as lymphomas, germ-cell tumors, Kaposi’s sarcoma, cervical
cancer, and squamous cell carcinomas of the head and neck (Sleijfer,2001). Through
induction of oxygen free radicals, bleomycin causes DNA strand breaks which ultimately
lead to tumor cell death (Schirner et al.,1998). Following administration, excretion or
deactivation by bleomycin hydrolase rids the body of the cytotoxic agent. However,
pulmonary toxicity may arise due to the lack of the bleomycin hydrolase enzyme in the
lung. BIP can occur in approximately 0 to 46% of patients and may progress to
pulmonary fibrosis if left undetected (Sleijfer,2001). Pulmonary abnormalities due to
bleomycin treatment can be reversible, but once the fibrotic process has begun this may
not be the case (Sleijfer,2001;Van Barneveld et al.,1987). The mortality rate of patients
with BIP is approximately 3% (Levi et al.,1993;Simpson et al.,1998).
A histological evaluation indicates that bleomycin-induced lung injury involves
squamous metaplasia of the bronchiolar epithelium, inflammatory cell infiltrate in alveoli
and alveolar septa, edema, and focal collagen depositions in the septa and fibrotic
areas (Bedrossian et al.,1973;Jones,1978). CT scanning also may reveal small linear
and subpleural nodular lesions in the lung bases (Rimmer et al.,1985). The disease
results from lung vasculature endothelial cell damage with edema, possibly from free
radical and cytokine production, followed by inflammatory cell influx and activation
(Adamson & Bowden,1974). Ultimately, activation of fibroblasts in the lung parenchyma
cause the development of fibrosis (Adamson & Bowden,1974;Piguet et al.,1993).
Occupational exposure to various substances in the workplace and/or
environment is another known cause of lung inflammation and fibrosis. Pulmonary
disease arising from acute or chronic occupational exposures is the leading cause of
2

work-related illness in the U.S. according to the 2002 report by the American Lung
Association. Asbestosis, silicosis, and coal workers’ pneumoconiosis (CWP) are well
described lung diseases that result from asbestos fiber, silica, or coal inhalation,
respectively. For example, silicosis in workers occurs in occupational settings, such as
mining, foundries, tunneling, rock drilling, sand blasting operations, stone cutting, clay
industries, and glass manufacturing, and claims the lives of 300 people per year
(American Lung Association, 2002). It is reported that approximately 1.6 million workers
have been exposed to silica dust and 60,000 workers may be affected by silica-induced
lung disease in the near future (American Lung Association, 2002). The following will
describe aspects of occupational lung diseases that may result from exposure to silica,
asbestos, or coal.
Varieties of silicosis, which depend on the level of dust exposure and the
resulting latency period for disease initiation and progression, include acute,
accelerated and chronic silicosis. Exposure to high levels of crystalline silica-containing
dusts results in acute silicosis, otherwise known as silicolipoproteinosis (Banks, 1996;
Peters, 1986) Pulmonary edema, interstitial inflammation, and the presence of
surfactant rich proteinaceous fluid in the alveoli are characteristic of the disease along
with an eosinophilic alveolar exudate (Vallyathan et al.,1995;Vallyathan et al.,1988).
Accelerated silicosis partially resembles acute silicosis however, this form of the
disease exhibits fibrotic granulomas consisting of collagen, reticulin, and silica particles
(Green & Vallyathan, 1996). Mononuclear cells, as well as fibroblasts are also present
in the circularly oriented granulomas (Green & Vallyathan, 1996). Prolonged exposure
to crystalline silica results in chronic silicosis (Castranova & Vallyathan,2000). Chronic
3

silicosis is characterized by silicotic nodules of up to 1cm in diameter (Scarisbrick,2002).
Nodules in the early stages of the disease consist of dust-laden macrophages arranged
around a collagen center but later this fibrosis progresses to a characteristic whorled
collagen pattern with decreased numbers of inflammatory cells at the periphery
(Mossman & Churg,1998). With progression of the disease, static lung volumes and
alveolar gas exchange decrease (Castranova & Vallyathan,2000).
Silicosis tends to be contained in upper zonal lung regions but lower regions may
become involved (Mossman & Churg,1998). Silicotic nodules in the lung appear blue to
green if exposure was to relatively pure silica, black if the disease forms in a coal miner,
or red if in a hematite miner (Mossman & Churg,1998). Simple CWP appears similar to
silicosis on chest radiographs but is characterized by black dust macules, which are
more cellular than silicotic nodules, in the upper lung lobes surrounded by dilated
respiratory bronchioles (Scarisbrick,2002). Development of progressive massive
fibrosis (PMF) from either silicosis or CWP can occur and is characterized by collagen
nodules which are larger than 1 cm and more numerous throughout the lung fields when
observed radiologically (Scarisbrick,2002).
Clinically, asbestosis is bilateral diffuse interstitial fibrosis resulting from asbestos
fiber inhalation (American Thoracic Society, 1986). The disease is typically
concentrated in the lower lung region closest to the pleura with central lung portions
spared (Mossman & Churg,1998). Diffuse interstitial fibrosis and asbestos bodies
consisting of asbestos fibers with an iron-protein coat are two required microscopic
findings for diagnosis (Craighead et al.,1982).

4

The pathogenesis of pulmonary fibrosis seems to follow a similar pattern.
Whether initiated by bleomycin, silica, asbestos, or coal, unresolved chronic
inflammation and production of proinflammatory and fibrotic mediators are a similarity
among the diseases (Mossman & Churg,1998). In general, an injury to the epithelium
and endothelium of the lung causes activation and recruitment of inflammatory cells
which release inflammatory mediators that induce further cell injury (Kuwano et
al.,2001). The activation and proliferation of fibroblasts results in ECM protein
deposition which, if allowed to progress past a critical point, may severely compromise
lung function (Kuwano et al.,2001;Selman,2002).
This study investigates the underlying inflammatory and fibrotic mechanisms
involved in occupational lung disease caused by exposure to crystalline silica and
fibers. Two topics are presented: 1.) The role of fiber dimension and chemical
composition on the response of alveolar macrophages (AMs) 2.) The role of inducible
nitric oxide synthase (iNOS) in silica-induced lung inflammation and fibrosis. The
second topic examines silica-induced responses and a classic experimental model of
lung damage and inflammation, i.e., lipopolysaccharide (LPS) exposure. Therefore, this
investigation involves a common theme that includes lung damage, inflammation, and
resulting fibrosis. First, general particle-induced toxicity mechanisms will be introduced
followed by particle specific mechanisms of lung damage and inflammation.

5

Particle Induced Lung Injury and Inflammation
Following inhalation of particles, the airways are cleared through the use of
highly effective defense mechanisms. In the ciliated airways, the mucociliary escalator
traps and removes particles from the lung, while in the alveolar region, AMs engulf
particles and transport them to the mucociliary escalator for removal (Donaldson &
Tran,2002). Introduction of a toxic particle to the lung can cause a pulmonary reaction,
which may involve one or more of the following pathogenic mechanisms: 1.) Direct
cytotoxicity 2.) Activation of phagocytes 3.) Inflammatory cytokine production and/or 4.)
Proliferative factor secretion (Castranova, 1998).
Particles that are directly toxic to lung cells induce lipid peroxidation, which
compromises the integrity of the cell membrane and results in cytotoxicity (Castranova,
1998). Crystalline silica and crocidolite asbestos have both been shown to induce lipid
peroxidation in greater amounts as compared to talc or kaolin (Faux &
Howden,1997;Vallyathan,1994). Crocidolite, for example, contains surface iron which
can generate hydroxyl radicals (OH˙) through Fenton-like reactions, and OH˙ are
thought to play a major role in the peroxidation of membrane lipids (Castranova, 1998).
In addition, Vallyathan et al. (1988) showed crystalline silica, when fractured, forms Si˙
and SiO˙ surface radicals that generate OH˙ in aqueous solutions. Silica dust can also
be contaminated by trace iron, which can participate in the Fenton reaction described
above. A direct link exists between the ability of a particle to cause lipid peroxidation
and its ability to generate OH˙ (Dalal et al.,1990b). Direct cytotoxicity can also include
the particle’s ability to induce “programmed cell death” or apoptosis. Data suggests that
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pathogenic particles, such as crystalline silica and crocidolite asbestos, induce
apoptosis where non-pathogenic particles do not (Holian et al.,1997;Iyer et al.,1996).
Particle-receptor binding may activate AMs and polymorphonuclear leukocytes
(PMNs). Cellular activation may result in the production of reactive such as superoxide
(O2˙-), hydrogen peroxide (H2O2), OH˙, and nitric oxide (NO) (Castranova,1994). The
formation of reactive oxygen species (ROS), known as the respiratory burst, involves an
essential multisubunit enzyme complex called the nicotinamide adenine dinucleotide
phosphate hydrogen (NADPH) oxidase. Assembly of the NADPH oxidase requires
activation of protein kinase C via receptor-mediated intracellular signaling events
(Qualliotine-Mann et al.,1993). PKC activation results in phosphorylation and
membrane translocation of the cytosolic components p47phox/p67phox/p40phox and
guanosine 5’-triphosphatase Rac1/Rac2 of the NADPH oxidase. The cytosolic
components then combine with the membrane-bound flavocytochrome subunits,
gp91phox and p22phox, completing the active oxidase which utilizes cytosolic NADPH to
reduce extracellular molecular oxygen (O2) to O2˙- (Griendling et al.,2000;Kanai et
al.,2001). The O2˙- can then be used to form other reactive species either through
enzymatic or spontaneous processes (Iles & Forman,2002).
Reactive nitrogen species (RNS) can also be formed from the cytosolic enzyme
iNOS or NOS2 present in pulmonary phagocytes. Exposure to crystalline silica causes
induction of mRNA for iNOS and the active iNOS protein utilizes the amino acid Larginine to form NO (Blackford et al.,1994). Exposure to asbestos also induces iNOS
and NO production (Dorger et al.,2002). NO, in the presence of O2˙-, can form
peroxynitrite, which can further react to yield OH˙ (Castranova, 1998). Compared to
7

crystalline silica, less pathogenic particles, such as titanium dioxide (TiO2) and carbonyl
iron, cause only a slight induction of iNOS mRNA (Blackford et al.,1997).
Secretion of inflammatory cytokines from pulmonary phagocytes is the result of
activation of transcription factors, such as nuclear factor-κB (NF-κB) and activator
protein-1 (AP-1), that modulate the expression of various inflammatory genes (Lenardo
& Baltimore,1989). NF-κB and mitogen activated protein kinases (MAPK) are examples
of signal transduction pathways known to be activated in response to changes in
cellular redox status and ROS due to the presence of inflammatory stimuli (Chen et
al.,1995b;Janssen et al.,1995;Lo et al.,1996;Meyer et al.,1993;Wilhelm et al.,1997).
The transcription factor NF-κB, a heterodimer of p50 and p65, resides in the
cytoplasm complexed with inhibitory kappa B (IκB) under basal conditions (Baeuerle &
Baltimore,1988). Upon cellular activation, phosphorylation of IκB releases the inhibition
from the NF-κB heterodimer and allows it to translocate to the nucleus where gene
transcription occurs (Iles & Forman,2002). The MAPK family includes extracellular
signal regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38 kinase.
Activation of MAPK proteins leads to activation of transcription factors, such as AP-1,
resulting in inflammatory gene expression (Rahman & MacNee,1998). Both the NF-κB
and MAPK pathways are activated by ROS induced by particles, such as glass fibers,
silica, and asbestos (Ding et al.,1999a;Ding et al.,1999b;Ye et al.,1999;Ye et al.,2001).
DNA binding by transcription factors causes production of mRNA for various
inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1
(IL-1), and the resultant secretion of these inflammatory mediators from AMs
(Castranova, 1998). TNF-α has multiple effects in the lung, including regulation of
8

chemokine production (i.e., macrophage inflammatory proteins, MIP-1 and MIP-2, and
cytokine-induced neutrophil chemoattractant or CINC and stimulation of fibroblast
proliferation (Driscoll et al.,1995;Driscoll et al.,1990;Gauldie et
al.,1993;Levine,1995;Martinet et al.,1996).
Inflammatory cytokine and chemokine secretion due to particle stimulation
ultimately results in PMN recruitment into the airspace. Influx of PMNs into the lung
increases the oxidant burden and damage to pulmonary tissue (Castranova, 1998).
The ability to recruit PMNs into the airspace correlates with the pathogenicity of the
particle. For example, in vivo, crystalline silica is more potent in increasing
bronchoalveolar lavage BAL PMNs as compared to TiO2, carbonyl iron, aluminum
oxide, amorphous silica, or iron oxide (Beck et al.,1982;Blackford et
al.,1997;Lindenschmidt et al.,1990;Warheit et al.,1991a;Warheit et al.,1991b).
A final mechanism in particle-induced pulmonary pathogenesis is the production
of proliferative factors from AMs and/or alveolar epithelial cells. Particle exposure and
the associated increased cytokine production have been shown to increase the
production of platelet-derived growth factor (PDGF), transforming growth factor-alpha
(TGF-α), and AM-derived growth factor in pulmonary cells (Lasky et al.,1995;Liu et
al.,1996;Rom et al.,1987). These factors directly stimulate interstitial fibroblasts to
produce ECM proteins causing lung fibrosis (Castranova, 1998).
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Fiber-Induced Lung Disease
Inhalation of asbestos fibers causes pulmonary fibrosis (asbestosis) and
malignancy (mesothelioma) in experimental animals and humans. Asbestos fibers are
crystalline 1:1 layer hydrated silicates of which there are 2 forms, serpentine and
amphibole asbestos. Chrysotile [Mg6Si4O10(OH)8] is a serpentine form. Amphibole
asbestos includes crocidolite [Na2(Fe3+)2(Fe2+)3Si8O22(OH)2], amosite
[(Fe,Mg)7Si8O22(OH)2], anthophyllite [(Mg,Fe)7Si8O22(OH)2], tremolite
[Ca2Mg5Si8O22(OH)2], and actinolite [Ca2(Mg,Fe)5Si8O22(OH)2] (Mossman &
Churg,1998). Chrysotile, the most common type, is a curly pliable fiber in comparison
to the rodlike shape of amphibole asbestos (Mossman & Churg,1998).
Commercial use of asbestos in the United States began in the early 1900s.
Numerous industries, including demolition, shipbuilding, construction, and automotive,
use the natural fibrous minerals for insulation and structural support due to its
resistance to thermal and chemical degradation (Jones et al., 1993). Due to its
fibrogenic and carcinogenic potential, asbestos use is restricted or prohibited in the
United States, although developing countries continue to rely on asbestos as a
commercial material (Manning et al.,2002).
Currently, man-made mineral fibers (MMMFs) produced from glass, natural
rock, or slag serve as asbestos substitutes for many industries (Jones et al., 1993).
MMMFs are believed to be a safe alternative to asbestos. However, their potential
pulmonary pathogenicity remains undefined (Bunn et al.,1993;Hesterberg et al.,1993).
Animal and in vitro data suggest pulmonary inflammation and possibly fibrosis may
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occur upon inhalation during manufacture and use of certain durable MMMFs
(Hesterberg et al.,1993).
Toxicity and carnicogenic potential of any fibrous particle is primarily determined
by dose, dimension, and durability (Oberdorster,2002). The dose of any respirable
particle is defined by the difference between the amount deposited in the lung and
amount cleared. Fibers having an aerodynamic diameter of <1µm are capable of
penetrating to the alveolar region of the lung (Dai & Yu,1998). Therefore, long,
potentially toxic, fibers (>20 µm in length) are effective in reaching the alveolar region of
the human lung (Dai & Yu,1998). The clearance of fibers from these deep lung regions
is dependent upon the ability of AMs to engulf and clear the deposited dosage. Another
important factor regarding fiber dose is the expression of dose as particle number rather
than particle mass. Occupational exposure limits are expressed as fiber number/cm3,
which has been accepted to be the most reliable dose parameter to evaluate pulmonary
responses to fibrous particles (Oberdorster,2000).
The dimension of a fibrous particle remains a primary area of research in fiber
pathogenicity and toxicity. Animal inhalation and intratracheal instillation studies have
shown a strong correlation between fiber length and toxicological potency (Adamson &
Bowden,1987;Davis et al.,1986;Davis & Jones,1988;Lemaire et al.,1985). Although
asbestos, regardless of dimension, possess additional characteristic that cause the
fibers to be pathogenic, inhalation and cellular studies show long fibers, in general, are
more cytotoxic, fibrotic, carcinogenic, and inflammatory than short fibers. Early work by
Stanton & Wrench (1972) and Pott et al. (1974) demonstrated that pleural and
peritoneal injection of fibers greater then 8 µm in length and <1-2 µm in aerodynamic
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diameter were more potent in inducing mesothelioma compared to shorter fibers.
Today many in vitro and in vivo animal studies have shown that long fibrous particles
stimulate a greater release of cytokines, chemokines, ROS, and other mediators and
cause increased cellular proliferation, fibrosis, tumors, and mesotheliomas in the lung
(Adamson & Bowden,1987;Davis & Jones,1988;Ishihara et al.,1999;Mossman,1990;Ye
et al.,1999).
Frustrated phagocytosis may be one of the processes contributing to the
increased toxicity observed with long fibrous particles. This process involves
incomplete or “frustrated” engulfment of fibers longer than the diameter of the
phagocytic cell. In comparison to short fibers that are fully engulfed by AMs and
subsequently cleared from the lung, longer fibers may cause sustained cellular
activation due to repeated attempts to engulf the fiber. Continual activation of various
pulmonary cells increases phagocyte recruitment into the airspace and subsequently
increases lung oxidant burden (Hansen & Mossman,1987;Oberdorster,2002;Vallyathan
et al.,1992).
The study of fiber length as a cause of toxicity has been complicated in the past
by the inability to obtain pure size-selected fiber samples. However, the development of
the dielectrophoretic classifier by Baron et al. (1994) has aided in the study of
monodisperse size-selected fiber samples on lung cell activation and toxicity. Fibers of
narrowly defined lengths are obtained by variation of the air flow and charge within the
dielectrophoretic classifier (Baron et al., 1994).
Blake et al. (1998) used the fibers generated by the dielectrophoretic classifier for
in vitro cytotoxicity studies of Manville code 100 (JM-100) glass fibers on primary rat
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AMs. The study showed AM viability and function decreased with in vitro fiber exposure
but a length dependent mechanism was evident. The 17 and 33 µm fibers, in
comparison to 3,4, and 7 µm glass fibers, caused the greatest degree of cytoxicity and
loss of rat AM function in vitro (Blake et al.,1998). Ye et al. (1999) also used the JM100 size-selected glass fibers to examine NF-kB activation and subsequent TNF-α
production in a mouse peritoneal macrophage cell line, RAW 264.7. Data showed short
fibers (7µm) were less potent activators of the NF-κB pathway as compared to the long
(17µm) glass fiber sample. TNF-α production was also greater upon stimulation with 17
µm glass fibers compared to the 7 µm glass fibers. These studies demonstrate that
fiber length plays a critical role in fiber induced cell activation and toxicity, but questions
still remain to whether length is a more important determinant of pathogenesis than the
chemical composition of the fibrous particle. It is of importance to note that even short
fibers elicit responses possibly leading to cellular changes and fibrotic responses if the
fibers persist in the lung. Thus, the chemical composition of the fiber (i.e. biodurability)
will be considered in the following section.
Biodurability aids in the determination of fiber biopersistence in the lung. Fiber
biopersistence encompasses both physiological clearance processes and
physicochemical processes such as fiber dissolution, leaching, mechanical breaking,
and splitting (Oberdorster,2002). The biodurability of the fiber directly correlates to its
toxicity and pathogenicity, and it is generally accepted that soluble fibers, regardless of
length, tend not to be carcinogenic whereas fibers that persist in the lungs, such as
amphibole asbestos fiber types, are carcinogenic (Oberdorster,2002).
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The physicochemical processes determine fiber biodurability and in part, fiber
reactivity in the lung. Following cellular uptake or adsorption of proteins or other
macromolecules to the fiber, surface characteristics of the fiber may be altered thereby
increasing or decreasing its toxicity to the lung (Mossman & Churg,1998). For example,
magnesium and iron, common elements found on some forms of asbestos can leach
from the mineral surface mediating cellular toxicity or reactivity as mentioned previously
(Jaurand et al.,1984). The following modified, iron-catalyzed Haber-Weiss reactions
can occur when iron, present on a fiber surface, is introduced into a biological system
(Hardy & Aust, 1995):
Reductant (n) + Fe (III)→
reductant (n+1) + Fe (II)

(1)

Fe (II) + O2→Fe (III) + O2˙-

(2)

HO2˙ + O2˙- + H+→ O2 + H2O2

(3)

Fe (II) + H2O2→ Fe (III) + OH- + OH˙

(4)

*Reaction 4 is the Fenton reaction
The production of the OH˙ radical via the Fenton reaction is extremely detrimental to
cellular DNA and may be the primary radical responsible for cancer induction (Hardy &
Aust, 1995).
The degree of pulmonary toxicity caused by fibers may depend upon dimension
and durability but the question remains as to which fiber characteristic plays a greater
role. Fibers that are chemically different from asbestos, a recognized carcinogen, have
been shown to cause pulmonary inflammation and fibrosis, as mentioned previously.
The possibility that the dimension of the fiber can cause increased reactive species
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production, which is known to play a role in the initiation and progression of pulmonary
disease, could have great implications for the future use of proposed asbestos
substitutes in the workplace. Using size-selected MMMFs of various lengths as well as
chemically variant fibers, such as chrysotile asbestos, ceramic, and glass fibers, the
question of dimension versus chemical composition is presently investigated.
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Silica-Induced Lung Disease
Inhalation of crystalline silica in various occupational settings, including
sandblasting, quarrying, stone dressing, refractory manufacture, or foundry work, can
result in silicosis (Mossman & Churg,1998). Various clinical and pathological varieties
of the disease exist as described previously.
Silica occurs naturally either in noncrystalline (amorphous) or crystalline forms.
Silica, in contrast to asbestos, is a compact particle with less than a 3:1 aspect ratio
(length to diameter) (Mossman & Churg,1998). Crystalline silica, as compared to
amorphous varieties, is known to be pathogenic in humans and is composed of silicon
and oxygen (SiO2) with trace quantities of Al, Fe, Mn, Mg, Ca, and Na (Mossman &
Churg,1998). α-Quartz, the most common form of crystalline silica, comprises nearly
67% of granite, shale, and sandstone; thus, significant exposure can occur in
occupations that involve blasting, grinding, or fracturing of these rocks (Mossman &
Churg,1998).
ROS produced either by silica or silica-stimulated cells may be mediators of
silica-induced inflammation, cytotoxicity, DNA modifications, and fibrosis (Daniel et
al.,1993;Mossman & Churg,1998;Shukla et al.,2001;Vallyathan et al.,1998). Electron
spin resonance (ESR) studies have shown that fractured silica generates silicon-based
free radicals (Si˙, SiO˙, SiOO˙) in air and OH˙ radicals when placed in aqueous
solutions (Dalal et al.,1990a;Shi et al.,1988;Vallyathan et al.,1992). As with asbestos
fibers, leached or adsorbed contaminates, such as iron, can also lead to OH˙ radical
formation via the Fenton reaction (Mossman et al.,1996;Schapira et al.,1995). The
surface production of reactive species by silica may lead to the oxidation of amino acids
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and sulfhydryl groups of membrane proteins and peroxidation of unsaturated fatty acids,
phospholipids, glycolipids and membrane sterols (Erdogdu & Hasirci,1998). An
additional source of ROS occurs when silica contacts cell membranes of phagocytic
cells, primarily alveolar macrophages and PMNs. Silica has been shown to increase
respiratory burst (i.e. cellular oxygen consumption) activity in phagocytes leading to the
production of reactive species, such as O2˙-, H2O2, and OH˙ (Vallyathan et al.,1992).
Coating the silica surface with substances, such as polyvinylpyridine N-oxide (PVNO) or
aluminum lactate, can decrease the generation of OH˙ radicals and the cytotoxic effects
of silica (Brown et al.,1989). In addition, (Gossart et al.,1996) showed that antioxidant
treatment can mitigate lung histopathology changes induced by silica. These studies
implicate ROS induced by silica or its surface as a possible mechanism in silica
pathogenesis.
Silica induced ROS production activates redox-sensitive transcription factors,
such as NF-κB and AP-1 (Baeuerle,1991;Janssen-Heininger et al.,2000). NF-κB
activation by silica has been shown to regulate gene expression of pro-inflammatory
cytokines including TNF-α (Rojanasakul et al.,1997;Savici et al.,1994). TNF-α has
been implicated in the initiation of pulmonary fibrosis as inhibition of TNF-α or the
soluble TNF receptors prevents silicosis in experimental models (Piguet & Vesin,1994).
TNF-α exhibits multiple roles in pulmonary fibrosis, including upregulation of collagen
and fibronectin gene expression, proliferation and activation of B and T lymphocytes,
increased arachidonic acid metabolism, oxidative burst and inflammatory cell
degranulation, and adhesion molecule expression (Mossman & Churg,1998).
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Evidence also exists that TNF-α alone does not initiate pulmonary fibrosis. In vivo data
show that TNF-α gene transfer produces relatively mild pulmonary fibrosis as compared
to TGF-β (Mauviel et al.,1988;Sime et al.,1998).
Macrophage inflammatory proteins, including MIP-1α, MIP-1β and MIP-2,
represent another subset of pro-inflammatory cytokines contributing to the inflammatory
and fibrotic response to silica exposure. MIP-2 is produced by silica-exposed
AMs,PMNs, bronchiolar and alveolar type II epithelial cells, as demonstrated by in vitro
studies with rat AMs (Driscoll et al.,1996). Homologous to the human gro cytokines,
MIP-2 has been shown to be involved in the development of silicosis and is highly
chemotactic for neutrophils, monocytes, lymphocytes, and eosinophils
(Driscoll,1994;Driscoll et al.,1993;Driscoll et al.,1996). Data show that inhibition of MIP2 attenuates the neutrophilic response of silica-exposed rats; therefore, indicating a
significant role for this chemokine in silica-induced inflammation (Driscoll et al.,1996).
Another molecule recently implicated in the pathogenesis of silica-induced lung
disease is the RNS NO. NO is formed from the conversion of the amino acid L-arginine
to L-citrulline in the presence of various cofactors and the enzyme nitric oxide synthase
(NOS). There are three described isoforms of NOS, iNOS or NOS2, and the
constitutive NOS isoforms endothelial (eNOS or NOS3), or neuronal (nNOS or NOS1).
The constitutive NOS isoforms, nNOS and eNOS, are present in nerve tissue, airway
epithelial and vascular endothelial cells in the lung, respectively, while iNOS is produced
in various lung cell types in response to certain inflammatory stimuli, such as endotoxin
(Mikawa et al.,1998). The present study will be concerned with iNOS due to its
implication in particle-induced lung inflammation and disease.
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The role of iNOS-derived NO in particle-induced lung disease remains unclear
with both anti-inflammatory and pro-inflammatory mechanisms being described. The
molecule NO is reactive and possesses both anti-microbial and anti-viral capabilities.
Antonini et al. (2001) reported the ability of NO to decrease the susceptibility of rats to
pulmonary infections. However, conflicting data show NO may inhibit or enhance the
activation of NF-κB, which ultimately effects the production of inflammatory cytokines
(Chen et al.,1995a;Kang et al.,2000b). NO also increases lung inflammation and
damage by combining with O2.- to form peroxynitrite (OONO-), a highly reactive species
that may cause lipid peroxidation, mitochondrial and DNA damage, as well as enzyme
and protein inactivation (Haddad et al.,1996a;Haddad et al.,1996b;Hogg &
Kalyanaraman,1999;van der Vliet et al.,1997).
Both animal and human data support a detrimental role for NO in particleinduced lung injury and disease. For example, the mouse peritoneal macrophage cell
line, RAW 264.7, show an increase in NO in response to in vitro silica exposure (Chen
et al.,1995a). Intratracheal instillation and inhalation exposures in rats further verify
increased NO production is associated with the lung injury caused by silica. Blackford
and colleagues (1997) reported that iNOS mRNA induction in BAL cells and NOdependent chemiluminescence from AMs correlated with the degree of pulmonary
inflammation caused by intratracheal instillation of rats with silica, coal, carbonyl iron, or
titanium dioxide. Castranova et al. (1998) reported the harvested AMs from coal-miners
exposed chronically to silica-containing dusts had enhanced NO-dependent
chemiluminescence and iNOS mRNA induction compared to AMs from a healthy nonsmoking subject. Furthermore, a chronic rat silica inhalation study by Porter et al.
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(2002) showed a temporal correlation between lung NO production and pulmonary
inflammation and fibrosis. Immunohistochemistry data also revealed that silicotic
lesions in the lung were associated with iNOS staining and nitrotyrosine residues which
is evidence of OONO-.
Based on the majority of evidence presented thus far, iNOS-derived NO appears
to assume a more detrimental role in the lung. A model of iNOS-derived NO deficiency,
the iNOS knockout mouse (iNOS KO), has recently been employed in studies involving
endotoxin, asbestos, and silica. Intratracheal instillation of asbestos in iNOS KO mice,
for example, resulted in an enhanced pulmonary inflammatory response (higher TNF-α
production and neutrophil influx) but attenuated oxidant-promoted lung tissue damage
as measured by decreased protein leakage and lactate dehydrogenase (LDH) into the
alveolar space (Dorger et al.,2002).

In addition, absence of inflammation and

attenuated fibrosis in silica-exposed iNOS KO mice was reported at certain timepoints in
a histological study by Srivastava et al. (2002). The present study investigates the
effect of iNOS-derived NO on pulmonary damage, inflammation and fibrosis in
crystalline silica or acute LPS exposures by comparing pulmonary responses in wild
type (WT) versus iNOS KO mice.
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STUDY 1
ROLE OF LENGTH AND CHEMICAL COMPOSITION ON FIBER-INDUCED EFFECTS
ON PRIMARY RAT OR HUMAN ALVEOLAR MACROPHAGES IN VITRO
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ABSTRACT
Studies show asbestos can lead to lung disease. Therefore, substitutes have
been developed that differ chemically from asbestos. However, fiber length as well as
chemical composition may be an important factor in pathogenicity. Our previous data
revealed length dependent cytotoxic and inflammatory effects of length-classified glass
fibers on rat alveolar macrophages (AMs) and on a mouse peritoneal macrophage cell
line (RAW 264.7), respectively, which were attributable to incomplete or frustrated
phagocytosis (Blake et al.,1998;Ye et al.,1999). Therefore, the first objective of this
study was to investigate the role of length and chemical composition by monitoring the
cellular effects of length-classified glass fibers (7 and 17 µm) or three types of fibers
(glass, chrysotile, or ceramic) of similar lengths on primary rat AMs in vitro. A
dielectrophoretic classifier was used to separate fibers into specified length categories.
Primary rat AMs obtained via bronchoalveolar lavage (BAL) were exposed to various
concentrations of fibers. Inflammatory potency was assessed by tumor necrosis factorα (TNF-α) release. The activation of the mitogen activated protein kinases (MAPK),
p38, ERK and JNK, was also examined as a pathway possibly involved in the TNF-α
production by rat AMs exposed to glass fibers. Data show long glass fibers (at a cell to
fiber ratio of 1:5) were three fold more potent than short glass fibers in stimulating TNFα. Long glass fibers were twice as potent as short glass fibers in activating p38 and
ERK. Therefore, glass fiber length is an important factor in AM activation. To
investigate the contribution of fiber chemical composition on AM inflammatory cytokine
production and cytotoxicity, rat AMs were exposed to chrysotile asbestos, glass, and
ceramic fibers of similar dielectrophoretic size cuts (17 µm). TNF-α, an indicator of
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inflammatory potency, was induced by all fibers. Chrysotile asbestos and glass fibers
induced greater amounts of TNF-α at all concentrations compared to ceramic fibers.
Stimulation with ceramic fibers only yielded a significant increase of TNF-α at the two
highest concentrations whereas, chrysotile asbestos and glass fibers caused a
significant increase at all concentrations. Only at 500 µg/ml was there a significant
difference in potency between glass fibers and chrysotile asbestos, with glass being a
stronger inducer of TNF-α. Chrysotile asbestos caused the greatest membrane
damage [measured via lactate dehydrogenase (LDH) activity], i.e., 100 µg/ml chrysotile,
glass, and ceramic fibers induced 30, 19, and 7% cell death, respectively. In addition,
chrysotile exposure also induced significantly more apoptosis than glass or ceramic
fibers. The results suggest that both length and chemical composition play a role in rat
AM activation and cytotoxicity.
The second objective was to examine the cellular effects of length-classified
glass fibers (8,10,16,20 µm) on human AMs. Human AMs are larger in comparison to
the rat, approximately 18 µm as compared to 13 µm, respectively. As mentioned
above, a substantially greater cytotoxicity to rat AMs was associated with long glass
fibers. Human AMs were obtained by segmental bronchoalveolar lavage of healthy,
non-smoking volunteers. AMs were treated with three different concentrations
(determined by fiber number) of the sized fiber samples for 18 hours in vitro.
Cytotoxicity, caused by the fibers, was assessed by monitoring cytosolic LDH release
and loss of function [decrease in zymosan-stimulated chemiluminescence (CL)].
Microscopic analysis indicated that human AMs were large enough to completely engulf
glass fibers which were 20 µm long. All fiber length fractions tested exhibited equal
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cytotoxicity, i.e. increasing LDH and decreasing AM-CL in the same dose-dependent
fashion. Therefore, the data indicate that because human AMs are larger than rat AMs
they are able to phagocytize longer fibers and the absence of frustrated phagocytosis
results in lower fiber toxicity in human AMs. These differences in the AM response to
long fibers between human and rat phagocytes should be considered when designing in
vivo exposures using the rat model.
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INTRODUCTION
Glass fibers are popular substitutes for asbestos in the building industry. Due to
their recent introduction into the workplace, health effects of glass fibers remain a
concern. Indeed, some animal studies suggest pulmonary inflammation and fibrosis
may occur upon inhalation (McConnell et al.,1999). It has been proposed that fiber
length, as well as chemical composition, plays a role in fiber health effects. Therefore, a
classifier has been developed that separates fibers by length using dielectrophoresis
that involves the movement of neutral particles in a gradient electric field (Baron et al.,
1994, Deye et al., 1999). Macrophage toxicity and activation have previously been
demonstrated in our laboratory using these length-classified fibers and indeed, fiber
length was an important determinant of macrophage toxicity and function. Long glass
fibers (17 µm) caused greater nuclear factor-κB (NF-κB) activation and subsequent
tumor necrosis factor-α (TNF-α) production by peritoneal macrophages as compared to
an equal number of short fibers (Ye et al.,1999). In addition, 17 and 33 µm glass fibers
caused similar rat alveolar macrophage (AM) cytoxicity and reduced function but at two
orders of magnitude less fiber number than 3,4, and 7 µm (Blake et al.,1998).
AMs act to clear the lung of foreign matter that reach the deep alveolar airway
regions. Some types of glass fibers, having an aerodynamic diameter of <1 um, can
penetrate to these regions and cause AM activation. Activated AMs can communicate
with other pulmonary and inflammatory cell types via cytokines and reactive species
(Driscoll et al.,1990;Gauldie et al.,1993). Previous data showed phagocytosis of glass
fibers in a mouse peritoneal macrophage cell line (RAW 264.7) resulted in TNF-α
production (Ye et al.,1999). TNF-α is a pro-inflammatory cytokine produced by
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macrophages early in inflammation and is important in the pathogenesis of pulmonary
fibrosis. TNF-α has been shown to stimulate fibroblasts resulting in production of
collagen matrix (Driscoll et al.,1990;Gauldie et al.,1993;Levine,1995;Martinet et
al.,1996).
The mitogen-activated protein kinases (MAPK) are activated by various stress
signals (Ono & Han,2000;Tibbles & Woodgett,1999). MAPK are serine/threonine
protein kinases that partcipate in signal transduction of many extracellular stimuli
including UV light, bacterial derivatives, growth factors, and reactive oxygen species
(ROS) (Ding et al.,1999a;Ono & Han,2000;Tibbles & Woodgett,1999). Activation of
these kinases involves phosphorylation of serine/threonine amino acid residues in their
protein molecule. The MAPK include extracellular signal-regulated kinase (ERK), p38
kinase, and Jun N-terminal kinase (JNK) (Karin,1995;Marshall,1995;Whitmarsh et
al.,1997). ERK, p38, or JNK act as signal tranducers at the end of the kinase cascade
that mediate signals from the cell membrane to the nucleus. Phosphorylation of the
MAPK leads to nuclear factor activation that regulate target gene expression. For
example, TNF-α transcription is controlled by multiple enhancer sites in the DNA such
as the k3 (a NF-kB binding site), cAMP response element (CRE), and activator protein1 (AP-1) site. These sites are regulated by transcription factors such as NF-kB, AP-1,
activated T cell factor (ATF-2), c-Jun, CRE-binding protein 1 (CREB 1), and nuclear
factor of activated T cells (Collart et al.,1990;Falvo et al.,2000;Rhoades et al.,1992;Tsai
et al.,1996a;Tsai et al.,1996b;Yao et al.,1997;Ye et al.,1999). The proteins c-Jun (a
constituent of the AP-1 dimer), ATF-2, and ElK1 are the major nuclear factors regulated
by the three MAPK.
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As mentioned above, MAPK pathways can be activated by ROS and previous
data by Ye et al. (1999) showed fiber-induced ROS were required for TNF-α production
in mouse peritoneal macrophages via an NF-κB dependent pathway (Ye et al.,1999).
Therefore, it is likely that MAPK will be activated by glass fiber-induced ROS from
primary rat AMs and this activation may be length-dependent.
The first objective of this study examined the role of fiber length and chemical
composition on fiber-induced cellular effects on the main lung phagocytic cell, the
alveolar macrophage. The contribution of fiber length on primary rat AM activation was
addressed by measuring inflammatory potency via TNF-α production after in vitro
exposure to 7 and 17 µm glass fibers. In addition, the role of the MAPK signal
transduction pathway in the induction of TNF-α was examined. To study the
contribution of the chemical composition of fibers, chrysotile asbestos, glass, and
ceramic fibers of the same length were used. Inflammatory potency and AM
cytotoxicity, due to different fiber chemical compositions, were investigated.
It is known that length dependent cellular effects occur when macrophages
engulf glass fibers and these effects were proposed to be due to incomplete or
frustrated phagocytosis of the fiber (Blake et al.,1998;Ye et al.,1999). Yet when
attempting to extrapolate fiber health effects to humans, the importance of macrophage
size becomes relevant because human AMs are larger in size than rat AMs,
approximately 18 and 13 µm in diameter, respectively. Therefore, the second objective
of this study was to expose human AMs in vitro to length-classified glass fibers and
compare the cellular effects to those obtained using the rat AMs. Decreasing cell
function and leakage of cytosolic LDH were evaluated as measures of toxicity.
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Microscopic analysis of fiber-cell interaction was also conducted to determine if
frustrated phagocytosis had occurred.
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METHODS
Fiber Samples- Bulk samples of JM-100 glass (Manville code 100 supplied by
John Mansville Corporation), chrysotile asbestos (IIT Research Institute), and ceramic
fibers (Fiberfrax 6000 Series Fiber from Unifrax) were first milled, aerosolized, and
separated into length categories using dielectrophoresis as previously described (Baron
et al., 1994; Deye et al., 1999). The dielectrophoretic classifier was operated in a
differential mode so that fibers with narrow length distributions were extracted in an air
suspension at the end of the classifier. These length-classified fiber samples were
collected on polycarbonate (Nuclepore) filters at rates up to 1mg/day. Fibers were
scraped off the filters for microscopic analysis and for biological experiments.
Samples of the length-classified fibers were prepared for size and count analysis
by adding weighed portions of the dusts to freshly filtered water. These samples were
then diluted and filtered through polycarbonate filters. Measurements of length, width,
and fiber count/mass were made using a JEOL JSM-6400 scanning electron
microscope (Blake et al.,1998). Measurements at each magnification were referenced
to a National Institute of Standards and Technology electron microscopy standard rule.
In this study, glass fiber samples with target lengths (means ± S.D.) of 7 (6.5 ±
2.7), 8 (7.96 ± 2.56), 10 (9.84 ± 3.09), 16 (13.28 ± 6.81), 17 (16.7 ± 10.6), and 20 (16.23
± 6.69) µm were used where indicated. Concentrations of the fibers in the first
experiment were expressed as fiber counts/ml. The glass fiber counts/mg were 3.0 x
108, 11.4 x 107, 8.95 x 107, 2.2 x 107, 2.0 x 107, and 2.92 x 107 for the 7,8,10,16,17, and
20 µm samples, respectively. For the chemical composition experiments, chrysotile
asbestos, glass, and ceramic fibers with target lengths of 17 µm were used at
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concentrations ranging from 25 µg/ml - 500 µg/ml. All fibers were heat-sterilized at 120
ºC for 2 hours and stored at 4-6 ºC. Prior to each experiment, the fibers were
suspended in sterile Ca+2 + Mg+2 free phosphate-buffered saline (PBS).
The endotoxin content of the fiber samples was measured using the Limulus
amebocyte lysate assay (Luoto et al.,1995). Values ranged from 0.7 to 1.69 endotoxin
units/mg. These values are orders of magnitude lower than those found with cotton
dust (1000-2000 endotoxin units/mg) or agricultural dusts (46-4000 endotoxin units/mg)
where endotoxin is thought to play a role (Castranova et al., 1992). The maximum
endotoxin concentration in this study was 0.013 ng/ml. This dose of endotoxin had no
effect on TNF-α production by macrophages because the minimum effective dose of
endotoxin is 1 ng/ml in this experimental system (data not shown). Therefore, the
results presented here can not be attributed to endotoxin contamination.
Rat Bronchoalveolar Lavage- Male weight-matched specific pathogen free
Harlan Sprague-Dawley rats purchased from Hilltop Labs (Scotdale, PA) were
euthanized using sodium pentobarbitol (>100 mg/kg i.p.). Following tracheal
cannulation, ice-cold, sterile, Ca+2 + Mg+2-free PBS was used to lavage the lungs at a
volume of 6 ml for the first lavage and 8 ml for subsequent lavages. For each rat, 80 ml
of bronchoalveolar lavage (BAL) fluid was collected in sterile centrifuge tubes. BAL
cells were washed twice in Ca+2 + Mg+2-free PBS by alternate centrifugation (500 x g,
10 min., 4 ºC) and resuspension. The washed cell pellet was suspended in HEPESbuffer (145 mM NaCl, 5 mM KCl, 10mM Na-HEPES, 1mM CaCl2, 5.5 mM glucose, pH
7.4). Cell counts were performed using an electronic cell counter equipped with a cell
sizing attachment (Coulter Multisizer II with a 256C channelizer, Coulter Electronics,
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Hialeah, FL). The number of alveolar macrophages was determined by their
characteristic cell diameter (Castranova et al.,1991).
Human Bronchoalveolar Lavage- Procedure was performed at University of
Pittsburgh and human alveolar macrophages were provided by the university. Briefly, a
total of six male healthy control subjects between the ages of 20 and 40 years were
recruited for study.

All signed a statement of informed consent approved by the

University of Pittsburgh Institutional Review Board for Biomedical Research. Subjects
were screened by history, physical examination, and spirometry. All subjects had to
exhibit normal spirometry, and have no history of asthma or allergic diseases. Skin test
responses to a panel of 15 common allergens, plus histamine phosphate as a positive
control (Greer Laboratories, Lenoir, NC), were determined using the prick-puncture
method. Any subject demonstrating a positive skin test to an allergen was deemed to
have atopic disease and was excluded.

Bronchoscopy and BAL were performed

according to published methods (Calhoun et al., 1992;Calhoun and Jarjour,1995;
Calhoun et al., 1994). Briefly, subjects were lightly sedated with midazolam 1.0mg and
atropine 0.5mg IM, and meticulous local anesthesia of the nasopharynx was obtained
using 4% cocaine solution, 1% lidocaine by gargle, and 1% benzocaine aerosol.
Additional topical 1% lidocaine, via the bronchoscope working channel, was applied to
the vocal cords and airway mucosa. Total lidocaine dose delivered below the vocal
cords was in all cases less than 200mg. The bronchoscope was advanced to the right
upper lobe, and wedged in a subsegment of the anterior segment.

BAL was then

performed using two aliquots of sterile saline solution (0.9% NaCl, 37 ºC, 60ml each),
recovered by hand suction. The bronchoscope was then moved to a subsegment of the
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right middle lobe, medial segment, and BAL was again performed.

Prior to

bronchoscopy, twenty one milliliters of blood were collected into sterile heparinized
tubes. Cells were recovered from BAL fluid by centrifugation at 400 x g for 15 minutes.
The resulting cell pellet was washed once with Hanks Balanced Salt Solution (HBSS,
Sigma, St Louis). Cells were counted using a hemocytometer, and adjusted to 2 x 106
cells/ml in HBSS..

Differential cell counts were performed on Diff-Quick stained

cytocentrifuge slides, and >300 cells were identified as alveolar macrophages,
lymphocytes, eosinophils, or neutrophils.

Viability by trypan blue exlusion always

exceeded 95%, and cell populations were in excess of 95% alveolar macrophages, with
the balance of the population comprised of lymphocytes. Neutrophils were rare, and
eosinophils were essentially never observed. In healthy volunteers, purification over
discontinuous Percoll gradients is unnecessary (Calhoun et al., 1992).
Tumor Necrosis Factor-α ELISA – Rat alveolar macrophages were plated in a
96-well plate at 1 x 105 cells/well in 200 µl of sterile Eagle’s modified essential medium
(EMEM) supplemented with 10% heat-inactivated fetal bovine serum, 1mM glutamine,
100 units/ml penicillin/streptomycin, and 10 mM HEPES at pH 7.2. After a 2 hour
incubation at 37 °C, the adherent cells were washed three times with warm sterile Ca+2
+ Mg+2-free PBS and then cultured in 200 µl fresh EMEM. The cell culture supernatant
was harvested after an 18 hour exposure to glass fibers at a cell to fiber ratio of 1:5
based on prior dose-response studies (Ye et al.,1999). In a separate experiment, rat
alveolar macrophages were exposed to chrysotile asbestos, glass, or ceramic fibers, at
various fiber concentrations ranging from 25 to 500 µg/ml at 37 °C, and the cell culture
supernatant was harvested at 6 hours to assess TNF-α production. An enzyme-linked
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immunosorbent assay (ELISA) kit (BIOSOURCE International, Camarillo, CA) was used
to determine rat TNF-α. ELISA plates were read at 450nm using a Spectramax 250
microplate spectrophotometer (Molecular Devices Corporation, Sunnyvale, CA).
Mitogen Activated Protein Kinase (MAPK) Phosphorylation Assay- Rat
alveolar macrophages were plated in a 6-well plate at 3 x 106 cells/well in 2 ml of
EMEM. After a 2 hour incubation at 37 °C, the adherent cells were washed with warm
sterile Ca+2 + Mg+2-free PBS and then exposed to glass fibers at a cell to fiber ratio of
1:5. After a 2 hour in vitro exposure, cells were washed once in Ca+2 + Mg+2-free PBS
and lysed in 200 µl lysis buffer for Western blot assay. Activation of ERKs, JNKs, and
p38 kinase was determined by their phosphorylation status detected with phosphospecific MAPK antibodies. ERK and p38 phosphorylation status was detected using
MAPK assay kits provided by New England Biolabs, Inc. (Beverly, MA). Phosphospecific and non-phospho-specific anti-JNK antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). The signal in Western blot was quantitated using
a densitometer and normalized for protein loading.
Lactate Dehydrogenase Activity- Lactate dehydrogenase (LDH) activity was
determined by monitoring the LDH catalyzed oxidation of pyruvate coupled with the
reduction of NAD at 340 nm using a commercial kit and a Cobas Mira Plus Transfer
Analyzer (Roche Diagnostics Systems, Montclair, NJ). In cases where data are
presented as percent maximum LDH release, alveolar macrophages isolated by
bronchoalveolar lavage from naive rats were lysed by sonication to determine maximum
LDH release.
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Apoptosis ELISA- Rat alveolar macrophages were plated in a 96-well plate at 1
x 105 cells/well in 200 µl of sterile EMEM supplemented with 10% heat-inactivated fetal
bovine serum, 1 mM glutamine, 100 units/ml penicillin/streptomycin, and 10 mM HEPES
at pH 7.2. After a 2 hour incubation at 37 °C, the adherent cells were washed three
times with warm sterile Ca+2 + Mg+2-free PBS and then cultured in 200 µl fresh EMEM.
Following a 6 hour exposure to chrysotile asbestos, glass, or ceramic fibers at
concentrations ranging from 25-500 µg/ml, the culture medium was removed and 200 µl
lysis buffer was added to the adherent cells. After a 30 minute incubation at room
temperature, the total lysate was transferred into sterile eppendorf tubes and
centrifuged at 500 x g for 10 minutes. The supernatant (cytoplasmic fraction) was then
collected and assayed immediately for apoptosis using a Cell Death Detection ELISAPLUS
(Roche Diagnostics Corporation, Indianapolis, IN). The ELISA is based on the binding
of mouse monoclonal antibodies against DNA and histones which allows the specific
detection of mono- and oligonucleosomes in the cytoplasmic portion of the lysate. The
detection of the nucleosomes is determined by a color reaction between POD
(peroxidase) and ABTS (substrate). For a quantitative measurement, ELISA plates
were read at 405nm using a Spectramax 250 microplate spectrophotometer (Molecular
Devices Corporation, Sunnyvale, CA).
Primary Human Alveolar Macrophage Zymosan-Stimulated
Chemiluminescence- Human alveolar macrophages were plated in a white opaque 96well plate at 1 x 105 cells/well in 200 µl of sterile EMEM supplemented with 2% heatinactivated fetal bovine serum, 1mM glutamine, 100 units/ml penicillin/streptomycin, and
10 mM HEPES at pH 7.2. After a 2 hour incubation at 37 °C, the adherent cells were
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washed three times with warm sterile Ca+2 + Mg+2-free PBS and then cultured in 200 µl
fresh EMEM. The cell culture supernatant was harvested after an 18 hour exposure to
8,10,16, or 20 µm glass fibers at approximately a 1:1, 1:8, or 1:80 cell to fiber ratio for
each fiber length. Harvested acellular supernatants were used to measure lactate
dehydrogenase activity as described above. Warm HEPES-buffered solution (pH=7.4)
was added to the alveolar macrophages on the plate which were then used to measure
zymosan-stimulated chemiluminescence. The lumigenic substance luminol (1mM) was
added to all wells of the assay plate followed by zymosan (2 mg/ml) or HEPES-buffered
solution to a final volume of 220 µl/well. Chemiluminescence was measured at 460 nm
using a microplate chemiluminometer (ML 3000 microtiter plate luminometer, Dynatech
Laboratories, Chantilly, VA) for 30 minutes and reported total cpm per well per 30
minutes. For control and fiber-stimulated cells, zymosan-stimulated chemiluminescence
was calculated as the stimulated (with zymosan) value minus the corresponding
unstimulated (without zymosan) value.
Microscopic Analysis- Photographs of human alveolar macrophages were
taken using an Olympus IX70 inverted light microscope equipped with a Dage camera.
Data analysis- The concentration-response curves for the cytotoxicity assays
using the three different fiber types were compared using a two-way analysis of
variance model. Pair-wise differences were assessed through appropriate contrast. In
addition, the apoptosis curves were compared, at each concentration, using a Student’s
t-test. All other data were analyzed using a Student’s t-test. A significant difference for
both tests was defined as p<0.05.
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RESULTS
Primary Rat Alveolar Macrophage TNF-α Production Following Exposure to 7 or
17 µm Glass Fibers- Figure 1 represents TNF-α production by rat AMs following in vitro
stimulation with 7 or 17 µm glass fibers. TNF-α protein was determined following an 18
hour incubation with the glass fibers. Results show a significant increase in TNF-α by
both short (7 µm) and long (17 µm) glass fibers in rat AMs as compared to control
levels. A differential potency was observed with the long glass fibers being
approximately three fold more potent in inducing TNF-α compared to the short glass
fibers.
Activation of MAPK by Glass Fibers- To determine a possible mechanism for
induction of TNF-α in primary rat AMs, the MAPK members, p38, ERK and JNK were
analyzed in this study. In vitro exposure of rat AMs to short (7 µm) and long (17 µm)
glass fibers resulted in phosphorylation of p38 MAPK as shown in Figure 2A. Data
show long glass fibers exhibited a stronger activity compared to short glass fibers.
Phosphorylation of p38 was induced by 7-fold and 3.5-fold after exposure to long and
short glass fibers, respectively, as compared to control (Figure 2B).
Figure 2C shows ERK phosphorylation status after rat AM treatment with short
and long glass fibers. Data show ERK phosphorylation was induced by 10-fold and 7fold after exposure to long and short glass fibers, respectively (Figure 2D).
JNK MAPK was also investigated in this study. JNK was not activated by either
short or long glass fibers (data not shown). Therefore, p38 and ERK appear to be the
major components in the signal transduction pathway for TNF-α induction by glass
fibers.
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Primary Rat Alveolar Macrophage TNF-α Production Following Exposure to 17
µm Chrysotile, Glass, or Ceramic Fibers- Fibers of different chemical compositions were
used to stimulate rat AMs for 6 hours and TNF-α protein was measured in the acellular
supernatant. Figure 3 shows the results of chrysotile asbestos and glass fiber exposure
on rat AMs in vitro. Both fiber types induced TNF-α at all doses. No significant
difference was found between the potency of chrysotile and glass fibers except at the
500 µg/ml dose where glass was found to be more potent. This result may be due to
the higher cytotoxicity associated with the chrysotile fiber compared to the glass. In
vitro stimulation with ceramic fibers significantly increased TNF-α only at the 250 and
500 µg/ml doses, i.e., increasing TNF-α production to 130 and 180 pg/ml, respectively
(data not shown).
Chrysotile, Glass, or Ceramic Fiber Induced Cytotoxicity in Primary Rat Alveolar
Macrophages- Rat AM cytotoxicity due to necrosis (i.e., cytosolic LDH release) (Figure
4) or apoptosis (Figure 5) was found to be concentration-dependent for each fiber type.
However, chrysotile exhibited the highest degree of cytotoxicity as compared to glass or
ceramic. For example, at 100 µg/ml chrysotile asbestos induced 30% necrosis as
compared to 19% and 7% for glass and ceramic fibers, respectively. Overall, the
apoptosis concentration curve for chrysotile asbestos was found to be significantly
higher than the glass and ceramic fibers, although caution should be taken in
interpreting significance at the 500 µg/ml dose due to greater data variability. Glass
fibers and ceramic exposure resulted in minimal to no apoptotic effects in the rat AMs.
Glass Fiber Induced Cytotoxicity in Primary Human Alveolar MacrophagesFigure 6 shows glass fiber-induced LDH release in human AMs. The fiber lengths
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tested (8,10,16, and 20 µm) all exhibited equal cytotoxic effects, and these effects were
not significantly different among fiber length groups of the same concentration group or
between concentration groups.
Human Alveolar Macrophage Zymosan-Stimulated Chemiluminescence- Human
AM zymosan-stimulated chemiluminescence following in vitro exposure to lengthclassified glass fibers is shown in Figure 7. Zymosan, a particulate B-glucan from yeast
cell walls, was used to stimulate reactive species production in the human AMs exposed
to glass fibers. Data show a concentration-dependent decrease in AM function (i.e.
reactive species production) with increasing fiber dose. Fiber length did not significantly
effect human AM function. It is of interest to note that the lowest dose group of lengthclassified fibers caused a significant priming of zymosan-stimulated reactive species
production from the human AMs compared to control levels.
Microscopic Examination of Primary Human Alveolar Macrophages Exposed to 8
and 20 µm Glass Fibers- Figure 8A demonstrates the ability of human AMs to engulf 8
µm glass fibers in vitro. Figure 8B demonstrates that human AMs can successfully
engulf 20 µm glass fibers. These results suggest human AMs can completely
phagocytize fiber lengths that rat AMs can not. Therefore, frustrated phagocytosis and
its possible effects are not a factor in this experimental system.
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DISCUSSION
Previous studies have shown that rat alveolar macrophages and mouse
peritoneal macrophages attempt to phagocytize glass fibers and that successful
engulfment is influenced by fiber length (Blake et al.,1998;Ye et al.,1999). Short (7 µm)
glass fibers were completely engulfed, whereas long (17 µm) glass fibers were only
partially engulfed.
The present study demonstrated attempted phagocytosis of short and long glass
fibers by rat AMs results in TNF-α production and MAPK activation. Long glass fibers
were approximately two to three times as potent in inducing TNF-α and activating MAPK
than short glass fibers. Previous studies from our lab also revealed long glass fibers
are approximately two to three times as potent than short glass fibers in inducing TNFα production and activating NF-κB in mouse peritoneal macrophages (RAW 264.7) (Ye
et al.,1999). Although the data correlate, the production of TNF- α by primary AMs in
comparison to the immortalized RAW 264.7 cells differed tremendously. Ye et al.
(1999) reported RAW 264.7 cells produced TNF-α at levels of 500 and 1500 pg/ml after
short and long glass fibers stimulation, respectively. The present study observed a
significantly higher level of production by primary rat AMs in response to glass fibers,
approximately a 12 to 13 fold difference. These data reveal that the peritoneal
macrophage RAW 264.7 cell line is not as sensitive to glass fiber stimulation which
may, if considered solely, underestimate the ability of glass fibers to induce high levels
of TNF- α. Therefore, the present study may more adequately represent the immediate
lung response when fibers are inhaled due to AMs being the principal lung phagocyte
and the initial target of glass fibers.
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In this study an equal number (1:5 cell to fiber ratio) of long or short fibers were
used to stimulate rat primary AMs in vitro. Although occupational standards for fiber
exposure are based on fiber number rather than mass, this does not account for fiber
surface area. It has been hypothesized that particle surface area plays a significant role
in the pulmonary response to particles of the similar chemistry and reactivity
(Oberdorster,2002;Oberdorster et al.,1994). Driscoll et al. (1996) showed a stronger
correlation exists between rat lung tumor incidence and particle surface area/lung rather
than particle mass/lung. For example, an animal study by Heinrich et al. (1995) showed
“ultrafine” titanium dioxide (particle size ~20 nm), at a 25 fold lower concentration,
elicited more lung tumors in rats when compared to a study by Lee et al. (1985) using
“pigment grade” titanium dioxide (particle size ~300 nm). In addition, Oberdorster et al.
(1994) reported that, at similar lung burdens, high surface area “ultrafine” titanium
dioxide (particle size ~20 nm) particles exhibited increased lung retention, interstitial
translocation, and decreased clearance, compared to “fine” (~200 nm) titanium dioxide
particles with a lower surface area.
The above mentioned studies involve spherical particles and do not mention the
effect of surface area for fibrous particles. Typically fiber length has been accepted to
be the most important characteristic contributing to fiber pulmonary effects however, it is
important to mention that total surface area does differ between the long and short
fibers. The total surface area of the 17 µm glass fibers was approximately 2.38 times
greater than the 7 µm fiber sample based on the formula for total surface area of a
cylinder [2 ∏ r (r+h)]. This figure correlates well with the two to three fold potency
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difference found for TNF- α production and MAPK activation suggesting if corrected for
surface area, these effects may be similar between the fibers.
Generation of reactive species occurs upon phagocytosis of short fibers.
However, it is likely that macrophages would generate more reactive species during
repeated, unsuccessful attempts to engulf fibers longer than the diameter of the cell. It
has been shown that reactive species, induced by silica and asbestos in vitro, cause
activation of NF-κB and MAPK pathways, and AP-1 which is regulated by MAPK
activation (Ding et al.,1999a;Kang et al.,2000a). As previously demonstrated, lengthclassified glass fibers activate NF-κB causing TNF-α production, which is inhibited by
the addition of the anti-oxidant N-acetyl-L-cysteine or the specific NF-κB inhibitor SN50
in RAW 264.7 cells (Ye et al.,1999). NF-κB activation and subsequent TNF- α
production was two to three fold higher upon stimulation with long (17 µm) glass fibers
compared to short (Ye et al.,1999). The present study also reported a two to three fold
higher potency of long glass fibers in activating MAPK and inducing TNF- α from
primary rat AMs. Several studies suggest the pattern of MAPK activation is stimulus
dependent (Ono & Han,2000;Tibbles & Woodgett,1999). For example, silica activates
p38 and ERK but not JNK, whereas asbestos activates ERK1 and ERK2 but not p38 or
JNK (Ding et al.,1999a;Ding et al.,1999b). This study reported activation of p38 and
ERK in glass fiber treated rat AMs (Figure 2).
To examine the contribution of chemical composition on inflammatory potency,
TNF-α production was also investigated using three different fiber types of similar
lengths. Elevated levels of TNF-α in the lung are known to be associated with diseases
such as pulmonary fibrosis (Driscoll et al.,1990;Gauldie et al.,1993;Levine,1995;Martinet
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et al.,1996). Figure 3 demonstrates both chrysotile asbestos and glass fibers induced
TNF-α at equal concentrations from rat AMs. However, chemical differences between
chrysotile asbestos and glass fibers did not play a role in production of TNF-α in this
experimental system. Chrysotile asbestos did exhibit higher cytotoxicity as compared to
the glass fibers, possibly resulting in an underestimation of the inflammatory potency of
chrysotile asbestos. Ceramic fibers were not as potent a stimulant of TNF-α production
from rat AMs in vitro. In contrast, studies by (Cullen et al.,1997) and Leikauf et al.
(1995) showed ceramic fibers induce TNF- α from rat AMs in vitro at levels similar to
code 100/475 glass fibers and crocidolite asbestos. The discrepancy could result from
the short exposure period (~ 6 hours) used in this study, as compared to approximately
24 hours in other reports. Possibly, the rat AM TNF-α response varies with each
stimulus and may be initiated slower by ceramic fibers than other fiber types.
The cytotoxic effects of chrysotile asbestos, glass, and ceramic fibers were
analyzed using LDH and apoptosis as cell death indices. Both measures of cell death
revealed chrysotile asbestos is more toxic to AMs than glass or ceramic fibers as shown
in Figures 4 and 5. It is interesting to note that apoptosis was not significantly elevated
from control by glass fibers except at the 250 µg/ml concentration while ceramic fibers
showed no significant apototic effects at any concentration. Chrysotile asbestos, on the
other hand, showed significant apoptotic effects at all doses except the lowest dose.
Cell death evaluated by cytosolic LDH release, was also found to be significantly
greater for chrysotile asbestos than glass or ceramic fibers, approximately 30, 19, and
7% at a concentration of 100 µg/ml, respectively.
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It is known that the pulmonary pathogenesis of asbestos involves cytotoxic
effects as well as TNF-α production (Liu et al.,1998;Panduri et al.,2003). For example,
pathogenic particles such as chrysotile and crocidolite asbestos, and crystalline silica
induce apoptosis in human AMs in vitro while non-pathogenic particles (i.e., titanium
dioxide, wollastonite, and amorphous silica) do not (Holian et al.,1997;Iyer et al.,1996).
The present in vitro study further supports this hypothesis. Glass fibers, although
chemically different from asbestos, may also exhibit pulmonary effects as suggested by
this study. These data indicate length is a determinant of glass fiber cytotoxicity but
chemical composition also plays a role as cell death varied among fiber types.
Ceramic fibers, in this study, exhibited a weak potential to cause cell death or
TNF-α production from the primary rat AMs. Minimal cytotoxicity via necrosis was
observed and significant TNF-α was found only at the two highest concentrations.
Therefore, ceramic fibers elicited minimal in vitro effects which do not correspond with
the reported in vivo effects of ceramic fiber exposure. Davis et al. (1984) reported
inhalation of ceramic fibers (10 mg/m3) in rats, pulmonary neoplasms, as well as
tumours not associated with the lung, were evident in 24 of the 48 exposed animals.
Mast et al. (1995) also showed inhalation of various types of ceramic fibers by rats, at a
concentration of 30 mg/m3, increased pulmonary neoplasms in all of the exposed
groups. Possibly the discrepancy between this study and in vivo reports is accounting
for durability of the fibers which is very different in the lung environment compared to
cell culture. Ceramic fibers in vivo are reported to be slightly less durable than asbestos
therefore, lung tumors associated with ceramic fiber exposure in rats may related to
their ability to persist in the lung (Muhle et al.,1994).
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The response of primary human AMs to length-classified glass fibers was also
investigated. Human AMs have a greater diameter than rat AMs; therefore it was
hypothesized that human AMs, may be able to engulf longer fibers than rat AMs.
Human AM cellular function, assessed by AM-CL, was significantly affected by fiber
concentration as shown in Figure 7 but not fiber length. Lower fiber concentrations
primed the AM-CL response while higher concentrations decreased this response.
However, it was found that no fiber length or concentration induced significant cellular
membrane damage as assessed by cytosolic LDH release into the cellular supernatant
(Figure 6). Castranova et al. (1980) reported effects of metallic ions on oxygen
consumption and chemiluminescence in AMs occur at doses that do not affect the
integrity of the cellular membrane. Therefore, a reason for the lack of a significant LDH
concentration-response may be that the cellular function is typically affected before
membrane damage making the AM-CL a more sensitive measure of cytotoxic effects.
This study reported no effects of fiber length on the human AM response. This
somewhat correlates with data by Blake et al. (1998) where increased glass fiber
concentration decreased AM-CL and increased LDH in rat AMs but major length
dependent effects were evident. The reason for this discrepancy most likely is due to
the lack of frustrated phagocytosis in the human AMs. Microscopic analysis verified
these cells were able to completely engulf even the longest fiber sample. Blake et al.
(1998) demonstrated cellular effects on rat AMs (diameter ~13 µm) using 17 and 33 µm
glass fibers, approximately 4-20 µm longer than the cells. This study was only able to
obtain a 20 µm glass fiber, only 2 µm longer than the human AM cellular diameter;
therefore not a sufficient length to cause frustrated phagocytosis. Consequently, further
44

studies are needed using fiber samples of at least 30-40 µm in length. Assuming similar
mechanisms are involved in human and rat fiber phagocytosis, results most likely would
agree with those reported by Blake et al. (1998).
The continued use of the monodisperse length-classified fiber samples will aid in
the determination of fiber health effects. This study showed: 1.) AMs, both human and
rat, are activated by glass fibers of monodisperse lengths. 2.) Rat AMs show a
differential activation due to fiber length that was not seen in the human AMs but further
studies are needed. 3.) Chemical composition also plays a role in fiber-induced cellular
effects.
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Figure 1- TNF-α production in primary rat alveolar macrophages exposed to lengthclassified glass fibers. Cells were exposed for 18 hours to 7 or 17 µm glass fibers at a
cell to fiber ratio of 1:5 (equal to 75 µg/ml for the long fiber and 8.7 µg/ml for the short
fiber). Bars represent mean value ± S.D. from five independent experiments. * or +
indicates a significant increase in TNF-α production compared to control for the short
and long fibers, respectively (p<0.05).
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Figure 2- Glass fiber-induced activation of p38 and ERK MAPKs. Phosphorylation
status of p38 and ERK MAPKs were analyzed by Western blot following a 2 hour
incubation of the rat alveolar macrophages with 7 or 17 µm glass fibers (1:5 cell to fiber
ratio). Panels A and C are representative phosphorylation and total protein abundance
signals for p38 and ERK, respectively. Panels B and D are the densitometric values
obtained following protein normalization.
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Figure 3- TNF-α production in primary rat alveolar macrophages exposed to 17 µm
chrysotile asbestos or glass fibers. Cells were exposed for 6 hours to 17 µm chrysotile
asbestos or glass fibers at various doses. Bars represent mean values ± S.E. of four
independent experiments. a - indicates a significant increase in TNF-α production
compared to control; b - indicates a significant difference between glass and chrysotile
asbestos induced TNF-α production (p<0.05).
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Figure 4- Lactate dehydrogenase release from primary rat alveolar macrophages after
exposure to 17 µm chrysotile asbestos (∆), glass (○), or ceramic (◊) fibers for 18 hours.
Each point on the curve represent mean values ± S.E. of seven independent
experiments. Different letters indicate that the dose-response curves were significantly
different from the other (p<0.05).
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Figure 5- Apoptosis in primary rat alveolar macrophages after exposure to 17 µm
chrysotile asbestos (∆), glass (○), or ceramic (◊) fibers for 18 hours. Each point on the
curve represent mean values ± S.E. of four independent experiments. Different letters
indicate that the dose-response curves were significantly different from the other and *
or # indicates a significant increase from control for chrysotile asbestos and glass,
respectively (p<0.05). Caution should be taken in interpreting significance at the 500
µg/ml dose due to greater data variability.
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Figure 6- Glass fiber induced lactate dehydrogenase release from primary human
alveolar macrophages following 18 hour exposure. Bars represent mean values ± S.E.
of three independent experiments. No significant difference was found among fiber
length groups of a given dose or between dose groups of the same fiber length.
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Figure 7- Zymosan-stimulated human alveolar macrophage chemiluminescence
following 18 hour exposure to length-classified glass fibers. Bars represent mean
values ± S.E of three independent experiments. Between corresponding fiber lengths,
a- represents a significant difference from the lowest to middles fiber dose, b- from the
lowest to highest fiber dose, and c- from the middle to highest fiber dose. *- indicates a
significant increase from control, i.e., no fiber exposure (p<0.05). Fiber length did not
affect human alveolar macrophage function.
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B.

A.

Figure 8- Figure 8 shows microscopic analysis of primary human alveolar macrophages
engulfing glass fibers. Panel A demonstrates the ability of the alveolar macrophages to
engulf 8 µm glass fibers. Panel B verifies effective phagocytosis of 20 µm glass fibers
by human alveolar macrophages.
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STUDY 2
RESPONSE OF ALVEOLAR MACROPHAGES FROM INDUCIBLE NITRIC OXIDE
SYNTHASE KNOCKOUT OR WILD TYPE MICE TO AN IN VITRO
LIPOPOLYSACCHARIDE OR SILICA EXPOSURE
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ABSTRACT
The role of nitric oxide (NO) in pulmonary disease has been controversial with
both anti-inflammatory [scavenging radicals and inhibiting nuclear factor-κB (NF-κB)
activation] and pro-inflammatory (forming highly reactive peroxynitrite and augmenting
NF-κB activation by inflammatory agents) actions reported. Therefore, a study has
been initiated to determine whether deletion of the inducible nitric oxide synthase
(iNOS) gene in the C57BL/6J mouse alters the pulmonary alveolar macrophage (AMs)
response to lipopolysaccharide (LPS) or silica. The objective of the initial phase of this
study was to determine the difference in responsiveness of AMs, harvested from naive
wild type (WT) or iNOS knockout (iNOS KO) mice, to an in vitro LPS or silica exposure.
Primary AMs were obtained by bronchoalveolar lavage (BAL) from age- and weightmatched iNOS KO and WT mice. The cells were treated with interferon-gamma (IFN-γ)
(50U/ml), IFN-γ (50U/ml) + LPS (1µg/ml), LPS (0.01 -100 µg/ml), or silica (25 - 250
µg/ml). The following parameters were measured: nitrate and nitrite (NOx), tumor
necrosis factor-α (TNF-α), macrophage inflammatory protein-2 (MIP-2), intracellular
generation of the reactive oxygen species (ROS) hydrogen peroxide (H2O2) and
.-

superoxide (O2 ), and basal (unstimulated) total antioxidant capacity.
Data show a significant increase in NOx production upon exposure to IFN-γ +/LPS in the WT but not iNOS KO AMs. NOx production by iNOS KO or WT AMs was not
altered by in vitro exposure to LPS or silica alone. LPS, but not silica, induced TNF-α
and MIP-2 production in both iNOS KO and WT AMs. Statistical analysis of
concentration-response curves found a significant tendency for greater mediator
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production in the iNOS KO versus WT AMs. Basal intracellular production of H2O2 and
.O2 was significantly greater in the iNOS KO compared to WT AMs. In contrast, LPS-

(10 µg/ml) or silica- (100 µg/ml) stimulated intracellular oxidant production was lower in
iNOS KO AMs, but overall (basal + stimulated) inflammatory capacity was similar
between the cell types. The basal total antioxidant production of the iNOS KO AMs was
approximately two fold higher than the WT AMs.
In conclusion, certain compensatory changes appear to occur in AMs from iNOS
KO mice. In response to the inability to induce NO production, iNOS KO AMs exhibit
significantly higher basal generation of H2O2 and O2

.-

as well as higher total antioxidant

levels. In addition, LPS-induced TNF-α and MIP-2 production tend to be higher in AMs
from iNOS KO mice. Such compensatory changes in the AM response may affect the
response of iNOS KO mice to inflammatory exposures.

Keywords: nitric oxide, inflammation, alveolar macrophage, inducible nitric oxide
synthase, reactive oxygen species
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INTRODUCTION
Nitric oxide (NO) is a gas molecule derived from the conversion of the amino
acid L-arginine to L-citrulline in the presence of one of three isoforms of the enzyme
nitric oxide synthase (NOS). The constitutive NOS isoforms, neuronal (nNOS or NOS-I)
and endothelial (eNOS or NOS-III), are present in nerve tissue, airway epithelial, and
vascular endothelial cells in the lung in a normal physiologic state. In contrast, inducible
nitric oxide synthase (iNOS or NOS-II) is produced in various pulmonary cells during an
inflammatory state, although evidence does exist for the presence of low levels of iNOS
under normal conditions (Gaston et al.,1994;Kobzik et al.,1993).
In pulmonary inflammation and disease, elevated levels of NO derived from iNOS
may play protective and/or damaging roles in the lung (Rao, 2000). NO can be antimicrobial, anti-viral, and anti-inflammatory. NO decreases the susceptibility to
pulmonary infections and may inhibit nuclear factor kappa B (NF-κB) activation in
macrophages and subsequently decrease production of inflammatory cytokines, such
as tumor necrosis factor-α (TNF-α) (Antonini et al.,2001;Chen et al.,1995a). In addition,
.data suggest that NO, in a low superoxide (O2 ) environment, can decrease lipid

peroxidation, which also suggests a protective role (Rubbo et al.,1994). In contrast, NO
can produce both direct and indirect tissue damage through its reactive properties; i.e.
.combining with O2 to form highly reactive peroxynitrite (OONO-) (Castranova, 1998b).

Furthermore, NO has been reported to be pro-inflammatory by enhancing silicaactivated NF-κB, thereby increasing cytokine production by macrophages (Kang et
al.,2000b).
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Human and rat data suggest NO and its reactive intermediates, such as OONO ,
play a role in silica-induced lung inflammation and disease. A human study, comparing
a healthy control, a silica-exposed coal miner with a normal chest radiograph, and one
with an abnormal chest radiograph, showed induction of iNOS messenger RNA was
associated with the pathogenic state of the subject (Castranova et al., 1998). For
example, in alveolar macrophages (AMs) obtained from the exposed worker with the
abnormal radiograph, iNOS mRNA levels were significantly elevated above control.
Moderate levels were found in the exposed worker with a normal radiograph, and low
levels were found in the healthy subject (Castranova et al.,1998).
A long-term rat silica inhalation study by (Porter et al.,2002) showed after 16
days of exposure the levels of the stable oxidation products of NO, nitrate and nitrite, in
the bronchoalveolar lavage (BAL) fluid were significantly elevated in silica-exposed rats
compared to air-exposed animals. The time course for this elevation of NOx in BAL
fluid was similar to that for pulmonary inflammation and preceded the induction of
pulmonary fibrosis (Porter et al.,2002). Strong iNOS and nitrotyrosine
immunohistochemical staining were also associated with sites of silica-induced
granulomas and silica deposition in the rat lung tissue (Porter et al.,2002).
Blackford et al. (1997) reported iNOS gene expression and NO production were
associated with the acute inflammatory response of rats to silica, coal dust, carbonyl
iron, or titanium dioxide exposure and that the relative pathogenicity of each dust was
correlated with the capability to produce an increase in NO production. These data also
correlate with the pathogenicity of the dusts in humans, for example, occupational
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exposure limits are set much lower for silica and coal compared to carbonyl iron and
titanium dioxide (Blackford et al.,1997).
Evidence implicates NO as a detrimental agent in lung pathogenesis but
numerous questions remain as to the overall role of NO in both acute and chronic
pulmonary disease. The present study was initiated to examine the role of NO in an in
vitro model of acute inflammation using a gram-negative bacterial component,
lipopolysaccharide (LPS), or silica as stimulants (Mayeux, 1997).
This study employed the iNOS knockout mouse and its wild type (WT) strain
(C57BL/6J). The objective was to examine the response of the mouse primary AM,
obtained via BAL, to an in vitro LPS or silica exposure to determine if the inherent
activity of the AMs was affected by the deletion of the iNOS gene. The AM was the
focus of this investigation due to its central role in the inflammatory response and its
ability to produce substantial amounts of inflammatory mediators such as NO
(Castranova, 2000). The following indicators of AM activity were measured: TNF-α and
macrophage inflammatory protein-2 (MIP-2) levels, reactive oxygen species (ROS)
.(hydrogen peroxide [H2O2] and O2 ), NO production (measured as NOx), and total

antioxidant capacity.
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METHODS
Animals- Breeder pairs of iNOS KO mice along with WT strain (C57BL/6J) were
purchased from Jackson Laboratories (Bar Harbor, Maine). Animals were housed in an
AAALAC-accredited, specific pathogen-free, environmentally controlled facility and
allowed to acclimate at least 5 days prior to use. The mice were free of endogenous
viral pathogens, parasites, mycoplasms, Helicobacter and CAR Bacillus. Mice were
kept in ventilated cages, which were provided HEPA-filtered air, with Alpha-Dri virgin
cellulose chips and hardwood Beta-chips for bedding. Food and tap water were given
ad libitum. Naive male mice, 8-10 weeks old with an average body weight of 25 grams,
were used in this study (exceptions noted).
Verification of iNOS Gene Deletion- RT-PCR and the NOx assay (see below)
were done to verify the iNOS knockout status of the animals, either peritoneal or
alveolar macrophages were used to verify systemic knockout status. iNOS mRNA or
NOx production was measured in response to LPS ± IFN-γ as described below.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)- Twelve mice
(6 WT, average weight 23g; 6 iNOS KO, average weight 30g) were used to collect
peritoneal macrophages. Resident peritoneal macrophages were harvested from both
WT and iNOS KO mice by peritoneal lavage using 15 to 20 ml of sterile Ca 2+- and Mg
2+

- free phosphate buffered saline (PBS, pH=7.3-7.7) (Biowhittaker, Walkersville, MD) 4

days after i.p. injection of 2 ml of 4% thioglycollate broth (Difco, Kansas City, MI). Three
mice in each group were subjected to peritoneal injection with 0.5 mg/kg LPS 12h
before the harvest of macrophages. The cells were washed once with RPMI 1640
medium (Sigma, St. Louis, MO) containing 10% fetal bovine serum. A 3 ml aliquot of
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the cellular suspension at a concentration of 2 x 106 cells/ml was seeded into a 6 well
tissue culture plate. After a 2 hour incubation at 37 ºC, the cells were washed to
remove nonadherent cells. For RT-PCR, total RNA was extracted from peritoneal
macrophages using Tri RNA extraction reagent purchased from Molecular Research
Center, Inc. (Cincinnati, OH). PCR primers used were 5'-ACA TGC TAC TGG AGG
TG-3' (corresponding to the mouse iNOS gene coding region 1114 to 1130, GenBank
ID U43428) and 5'-ACA CCA CTT TCA CCA AG-3' (corresponding to the mouse iNOS
gene coding region 1620 to1604). The calmodulin binding domain (region 1580-1660)
of iNOS was replaced with the neomycin resistant gene in the original iNOS gene
knockout mice (Laubach et al.,1995). With the use of this PCR primer pair a 506 bp of
the iNOS fragment was amplified from WT macrophages challenged in vivo with LPS.
In contrast, the same fragment could not be obtained from the iNOS KO macrophages
either in control or after in vivo LPS stimulation. RT-PCR was performed using 1 µg of
RNA and the Access RT-PCR system purchased from Promega (Madison, WI).
Bronchoalveolar Lavage- Naive mice were weighed and euthanized with an
intraperitoneal injection of sodium pentobarbital (>100 mg/kg). The trachea was
cannulated with a blunted 22 gauge needle and BAL was performed using cold sterile
Ca 2+- and Mg 2+- free PBS at a volume of 0.6 ml for first lavage and 1ml for subsequent
lavages. Approximately 10 ml of bronchoalveolar lavage fluid per mouse were collected
in sterile centrifuge tubes. Cells from different mice were pooled and washed twice in
PBS by alternate centrifugation (600 x g for 10 minutes at 4º C) and resuspension. The
final pellet was suspended in sterile Eagle’s modified essential medium (EMEM)
(Biowhittaker, Walkersville, MD) supplemented with 10% heat-inactivated fetal bovine
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serum, 1mM glutamine, 100 units/ml penicillin/streptomycin, and 10mM HEPES at pH
7.2.
Cell Counts and Differentials- Cell counts were performed using an electronic
cell counter equipped with a cell sizing attachment (Coulter Multisizer II with a 256C
channelizer, Coulter Electronics, Hialeah, FL.). Alveolar macrophages were identified
by their characteristic cell diameter (Castranova et al., 1990).
Tumor Necrosis Factor-α and Macrophage Inflammatory Protein-2 AssaysUsing sterile conditions, primary alveolar macrophages were plated in 96 well plates at
1x105 cells/well in 200µl of EMEM and allowed to attach at 37º C for 90 minutes. The
wells were washed twice with warmed EMEM, to remove non-adherent cells. The
alveolar macrophage-enriched adherent cells were then exposed to various
concentrations of LPS from E.coli serotype 026:B6 (Sigma, St. Louis, MO) in 200µl of
fresh EMEM. In separate experiments, cells were also exposed to heat-sterilized aged
Min-U-Sil 5 silica (98.5% crystalline silica, particle diameter < 5 µm, US Silica, Berkeley
Springs, WV, USA) at doses ranging from 10-500 µg/ml or LPS (0.01µg/ml) + IFN-γ (75
U/ml). Silica concentrations produced minimal cytotoxicity as verified by previous 18
hour studies (data not shown). Cells were incubated for 6 and 18 hours at 37º C in the
presence or absence of stimuli. After incubation, plates were centrifuged at 600 x g for
10 minutes, and the supernatants were aliquotted and frozen at -80°C or -20°C for
TNF-α and MIP-2 analysis, respectively. After thawing at room temperature, the
supernatants were diluted and assayed using a mouse TNF-α ELISA (BioSource
International, Camarillo, CA) or a mouse MIP-2 ELISA kit (R & D Systems, Minneapolis,
MN) according to manufacturer’s instructions. ELISA plates were read at 450 nm using
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a SpectraMax 250 microplate spectrophotometer (Molecular Devices Corporation,
Sunnyvale, CA).
Determination of NOx: Nitrate (NO3-) and Nitrite (NO2-)- Primary alveolar
macrophages (5 x 105 cells/well) were plated in a 24 well tissue culture plate and
allowed to adhere for 90 minutes at 37°C. The wells were washed three times to
remove non-adherent cells. Various concentrations of IFN-γ (Biosource International,
Camarillo, CA) ± LPS were added in a total volume of 0.5 ml EMEM to the alveolar
macrophage-enriched adherent cells. [In this in vitro system, mouse alveolar
macrophages did not produce substantial amounts of NO in response to LPS alone.
Therefore, IFN-γ was added, since it has been shown to potentiate NO production in
response to LPS (Huffman et al.,1998). Cells were incubated for 24 hours in the
absence or presence of IFN-γ ± LPS and after centrifugation, the acellular supernatants
were harvested for NOx by flow injection analysis colorimetry at 540 nm using the
Griess reaction (Quick-Chem 8000, Lachat Instruments, Milwaukee, WI) as described
by Porter et al. (2002).
Intracellular O2 .- and H2O2 Detection by Confocal Microscopy - Detection of
intracellular reactive oxygen species production was done using 2′7′dichlorodihydrofluorescein diacetate (DCHF-DA) for H2O2 (Zamzami et al.,1995a) or
.-

dihydroethidium for O2 (Zamzami et al.,1995b) purchased from Molecular Probes
(Eugene, OR) using a previously described method (Ding et al.,2001). The protocol for
cell loading was as follows: primary alveolar macrophages (1x105/ml) were plated in a
24 well tissue culture plate on glass cover slips that were pre-treated for 1 hour at 37°C
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with EMEM + 10% FBS. The remainder of the procedure was carried out in the dark at
37°C in PBS + glucose (5mM). After a 1 hour incubation, alveolar macrophages were
washed once with Ca2+ + Mg2+ - free PBS + glucose (5mM) to remove unattached cells
and either dihydroethidium (10µM) or DCHF-DA (25µM) was added. Following a 15
minute incubation with the fluorochrome, cells were stimulated for 30 minutes with either
LPS (10 µg/ml) or Min-U-Sil 5 (100µg/ml). Alveolar Macrophages were then washed
with Ca2+ + Mg2+ - free PBS, fixed with 10% buffered formalin phosphate for 10 minutes,
and mounted on glass slides using Prolong Antifade (Molecular Probes). Slides were
imaged using a Zeiss LSM 510 (Carl Zeiss, Inc., Thornwood, NY) at a 512 x 512 pixel
size with a 63x oil immersion objective and a pinhole aperture setting of 98 µm.
Dihydroethidium was excited at 490 nm and detected at 620 nm. DCHF-DA was
excited at 488 nm and detected at 525 nm.
Image Quantification- Relative fluorescence intensity was obtained using
Optimas version 6.51 software (Media Cybernetics, Silver Spring, MD). Briefly, cellular
images were converted to an 8 bit gray scale and using an area morphometry macro,
the area, perimeter, and mean gray value (mGV) were obtained for each cell in the field.
A total of 50 random cells per group were used for the final intensity analysis. Data are
expressed as relative intensity (mGV x area)/cell.
Fluorescence-Activated Cytometry Sorter Analysis (FACS)- The procedure
for cell staining was identical to the confocal protocol except cells (1x106/ml) were
plated in a 6 well tissue culture plate without glass cover slips. After staining, cells were
suspended in 1 ml Ca2+ + Mg2+ - free PBS immediately before analysis using a
FacsVantage SE (BD Bioscience, San Jose, CA). All readings were observed on the
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FL2 channel. Dihydroethidium was excited at 490 nm and detected at 620 nm. DCHFDA was excited at 488 nm and detected at 525 nm. Cell preparations were analyzed for
mean fluorescence intensity.
Total Antioxidant Capacity- Pooled alveolar macrophages from 2-3 naive mice
were used to obtain a 106 cells/ml aliquot suspended in Ca+2- and Mg+2- free sterile
PBS. After sonicating on ice for a total of 30 seconds, lysed cells were centrifuged
(10,000 rpm, 30 minutes, 4ºC) and acellular supernatants were frozen at -70ºC in 0.2 ml
aliquots. Total antioxidant capacity of the supernatants was assessed using the
Bioxytech AOP-490 assay (Oxis Research, Portland, OR) which is based upon the
reduction of Cu2+ to Cu+ by all antioxidants in the sample. Using a SpectraMax 250
microplate spectrophotometer (Molecular Devices Corporation, Sunnyvale, CA) set to
490 nm, data were obtained from a standard curve of known uric acid concentrations
and expressed as “mM Uric Acid Equivalents.”
Statistical Analysis- Statistical significance for the confocal microscopy and
NOx data was determined using a Student’s t-test. The cytokine dose-response curves
were compared using a mixed model analysis of variance with a random effect for
blocks available in SAS Proc Mixed. A significant difference for both tests was defined
as p<0.05. In the cases where cells were pooled from multiple mice, the n is indicative
of the number of times the experiment was repeated and not the number of mice pooled
(i.e., 2-3 mice pooled equaled an n=1).
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RESULTS
Verification of iNOS Gene Deletion- Figure 1 (panel a) shows RT-PCR analysis
of peritoneal macrophages harvested from WT or iNOS KO mice after in vivo LPS
stimulation. As expected, the WT mice peritoneal macrophages show an increase in
mRNA for iNOS after in vivo LPS stimulation, while the iNOS KO mice macrophages do
not. Both cell types had no iNOS message present in the control state.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (panel b) verified equal gel
loading.
In response to IFN-γ, WT AMs produced significant levels of NO, measured as
NOx, in the cell culture supernatant compared to the control. Upon in vitro treatment
with IFN-γ + LPS, NOx levels in the supernatant further increased above the control.
iNOS KO AMs showed no significant change in NOx production with IFN-γ ± LPS
stimulation compared to the control (Figure 2).
TNF-α and MIP-2 Production - AMs from both WT and iNOS KO mice exhibited
a concentration-dependent increase in TNF-α and MIP-2 production after in vitro
exposure to LPS (0.01-10 µg/ml). Statistical analysis of the concentration-response
curves showed significant differences in cytokine production between the iNOS KO and
WT AMs. For TNF-α at 6 hours (Figure 3a) and MIP-2 at 6 and 18 hours (Figure 4a and
b), respectively, mediator production was significantly higher from iNOS KO AMs than
the WT AMs, specifically at the higher LPS doses (1 and 10 µg/ml). No significant
difference was found between the TNF-α curves at 18 hours (Figure 3b). Results after
6 hours of LPS ± IFN-γ exposure of WT and iNOS KO AMs were also found not to be
significantly different for either TNF-α or MIP-2 production (data not shown). In vitro
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exposure to silica did not induce production of TNF-α or MIP-2 in either iNOS KO or WT
AMs (data not shown). The lack of induction could not be attributed to cellular toxicity
given that the highest concentration of silica produced only approximately 17% cell
death after 18 hours stimulation (data not shown).
.Confocal Microscopy - Figure 5 shows the basal production of H2O2 and O2 in

primary AMs from WT or iNOS KO mice. Images are displayed in pseudocolor where
blue indicates areas of low intensity and increasingly high intensity areas are green<
yellow< red<white. The image obtained for the iNOS KO AMs had greater amounts of
high intensity areas than the WT AMs, indicating a higher level of ROS for iNOS KO
cells in the basal state.
Figure 6 represents the quantitation for the basal production of H2O2 (Figure 6a)
.and O2 (Figure 6b) for WT and iNOS KO AMs. Plotted on the y axis is relative

intensity/cell based on 50 cells/treatment. There was a significant difference in basal
.production of H2O2 and O2 between the WT and iNOS KO AMs. In both cases, the

iNOS KO AMs were found to have a higher basal level of ROS production.
Figure 7 shows the confocal images obtained for in vitro silica-stimulated ROS
production. Both WT and iNOS KO AMs showed an increase in ROS production upon
silica stimulation, however, when quantified the increase was significantly lower for the
.iNOS KO AMs (Figure 8a and 8b for H2O2 and O2 , respectively). It appears that

although silica stimulation, the increase in production above control, of ROS in the WT
AMs is significantly greater than the iNOS KO AMs, the total ROS production is
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approximately the same due to the heightened basal level of ROS production in the
iNOS KO AMs. Similar results were observed in the LPS-stimulated AMs (images not
.shown) as shown in Figures 9a and 9b for H2O2 and O2 , respectively, with LPS-

stimulated ROS being greater in WT than in iNOS KO AMs.

It is evident that the iNOS

KO AMs are hindered in their ability to respond to a stimulus, i.e. the response to LPS
or silica stimulation of iNOS KO AMs was always significantly less than the WT.
FACS - The experiments performed with the confocal microscope were
replicated using flow cytometry as an additional method to verify the findings. Figure 10
is a representative histogram showing silica-stimulated H2O2 release from WT AMs.
The mean fluorescence for the basal release of H2O2 was 33 in the WT AMs. Upon
silica stimulation, a greater than 5-fold increase in mean fluorescence was observed.
This is apparent by the shift of the histogram to the right indicating increased cellular
.fluorescence. The basal release of H2O2 and O2 , represented as mean fluorescence in

Table 1, further confirm that the iNOS KO AMs have a greater basal production of these
ROS compared to the WT AMs, approximately 5- and 2.4- fold for H2O2 and O2

.-

,

respectively. When stimulated in vitro with LPS or silica (Table 1) the data indicate that
.the inducible increases of H2O2 and O2 are less in the iNOS KO compared to the WT.

For example, silica caused an increase of H2O2 in the WT AMs of 536% compared to an
increase of 114% in the iNOS KO AMs.
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Total Antioxidant Capacity - Basal total antioxidant capacity was significantly
greater in the iNOS KO AMs than those from WT mice. A two fold difference was
observed between the iNOS KO and WT AMs as shown in Figure 11.
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DISCUSSION
The objective of this study was to determine if the inherent activity of AMs was
affected by the knockout of the iNOS gene. The response of primary AMs harvested
from naive iNOS KO or WT mice to in vitro exposure to LPS or silica was examined.
Since AMs play a central role in the inflammatory response of the lung to occupational
particulates via increased NO, ROS and cytokine production, the focus of this study was
to characterize this cell type in terms of NO, TNF-α, MIP-2, ROS, and total antioxidant
production. Data confirmed the iNOS KO status of the mice by showing no measurable
increase in NOx production from primary iNOS KO AMs when stimulated in vitro with
IFN-γ ± LPS. In addition, RT-PCR data showed the absence of iNOS mRNA after in
vivo LPS stimulation in peritoneal macrophages harvested from the iNOS KO mice,
while induction was found in the WT.
Regarding a compensatory mechanism of the iNOS KO AMs or a difference in
responsiveness to LPS or silica, it was observed that in response to in vitro treatment
with LPS the cytokine concentration-response curves were significantly different
between the iNOS KO and WT AMs for both TNF-α and MIP-2 measured at 6 hours,
and at 18 hours for MIP-2 only. TNF-α and MIP-2 production by iNOS KO AMs tended
to be higher than the WT, especially at the higher LPS doses of 1 and 10 µg/ml. Chen
et al. (1995a,1995b) suggested iNOS-derived NO may act in a negative feedback loop
to suppress LPS and silica-induced NFκB activation causing decreased NFκB
dependent cytokine gene expression. Absence of this suppressive effect of NO in the
iNOS KO mouse may have enhanced the cytokine response to LPS. However, even
though the curves were significant, such differences between cytokine production of the
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iNOS KO and WT AMs were not strikingly large. Therefore, caution should be taken in
interpreting the cytokine data to be a major compensatory mechanism of the iNOS KO
AMs.
In vitro exposure of iNOS KO or WT mouse AMs to silica failed to elicit a
cytokine response. In contrast, silica induces TNF-α in an in vivo mouse model
(unpublished data). The reason for the difference between the response of mouse AMs
to an in vivo versus in vitro exposure to silica may be due to the lack of certain cell-cell
communications in the in vitro exposure system. The importance of such cell-cell
interaction has been demonstrated and was used to explain the lack of NO release
upon in vitro silica exposure of rat AMs in contrast to substantial silica-induced NO
production by iNOS after in vivo exposure of rats to silica (Huffman et al., 1998).
In contrast to the lack of a silica-induced cytokine response in mouse AMs after
in vitro exposure, primary rat AMs treated in vitro with silica have been shown to
produce small amounts of TNF-α (Dubois et al.,1989). A possible explanation for this
difference may be that an ELISA was employed to measure TNF-α in the present study
while Dubois et al. (1989) and Driscoll et al. (1990) used a bioassay system. Although
widely used, this bioassay determines TNF-α bioactivity via TNF-α induced cell lysis of
murine L-929 fibroblast cells (Flick & Gifford,1984). This detection method does not
account for effects of reactive species or the cross-reactivity of other ligands, such as
with interleukin-1 (IL-1), with the TNF-α receptor causing a decrease in cell viability.
This assay has also been reported to be highly variable (Dubois et al., 1989, Sadick et
al., 1999).
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The difference in silica-induced cytokine production by mouse versus rat AMs
after in vitro exposure may also reflect a species difference. Indeed, the rat has been
reported to be more responsive to in vivo exposure to silica than the mouse with the rat
demonstrating high susceptibility to silica-induced fibrosis and silica-induced lung
cancer while the mouse model exhibits lower pulmonary fibrosis and no lung tumors
(Saffiotti et al., 1996).
Interestingly, the data from both the confocal microcopy and flow cytometry
studies show that in the basal state the iNOS KO AMs exhibit an increased production
.-

of both O2 and H2O2 compared to the WT AMs. In contrast, LPS or silica stimulation
produced a greater induction of ROS production from the WT AMs. However, the total
ROS capacity (basal plus stimulated) was comparable between the two cell types.
Several possibilities were considered to explain these findings. First, NO is known to be
.-

a scavenger of O2 ; therefore, if NO is not present in the case of the iNOS KO AM then
.-

it is possible that there would be a greater amount of O2 present (Castranova, 2000).
However, our 30 minute stimulation with LPS or silica would not be enough time for
iNOS mRNA induction and iNOS protein synthesis in the WT AM, because it is known
that iNOS mRNA is upregulated in vivo approximately 4 hours after stimulation, while
NO production required approximately 8 hours to be significantly increased (Castranova
et al., 1998). In addition, under normal basal conditions iNOS in rat AMs is not present
(Miles et al.,1998). Rat AMs do contain eNOS under basal conditions (Miles et
al.,1998). However, basal NO production, possibly from eNOS, by WT and KO AMs
does not differ significantly (Figure 2). Therefore, the possibility of NO affecting the
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basal production of O2 seems unlikely. A second possibility involves NO being a
suppressor of the NADPH oxidase system, which produces ROS (Fujii et
al.,1997;Rodenas et al.,1998). Without NO, the inhibition of this system would be
absent allowing increased production of ROS in the iNOS KO AMs. The same
argument can be applied in this case, that iNOS-derived NO could not act as a
suppressor because it is not present in AMs under basal conditions and constitutive NO
levels in WT and iNOS KO AMs were found to be similar. On the other hand, data
suggest that low levels of iNOS are present in cells of the upper airways in rat and
humans under normal physiologic conditions (Gaston et al.,1994;Kobzik et al.,1993);
Castranova, 1998a). However, this was not noted in rat alveolar epithelial cells in the
basal state, which would be closely associated with AMs (Miles et al.,1997). It does not
appear likely that NO produced in the upper airways would act in the alveolar region of
the lung.
Our data also showed the increased basal ROS production was associated with
a concomitant two-fold increase in the total antioxidant capacity of iNOS KO AMs and
this increase possibly was attempting to restore the redox balance in the iNOS KO AMs.
It is hypothesized that the antioxidant capacity of the iNOS KO AMs alone was unable
to fully compensate for the heightened basal ROS production in the cells but in vivo the
situation may be resolved due to the contribution of other pulmonary cell types. Type II
cells, for example, have great capacity to accumulate antioxidants, such as ascorbate,
which may aid in protection from oxidative stress in vivo (Castranova et al.,1983).
Because the antioxidant measurement in the present study was obtained from lysed
naive AMs only, other pulmonary cell types which may contribute to restoring redox
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balance are not accounted for in this experiment. Future in vivo studies, particularly first
fraction BAL fluid analysis, are planned and will aid in determining the redox status of
the pulmonary system.
In conclusion, the increased levels of ROS in the basal state by iNOS KO mice
represents a compensation for the loss of nitric oxide, an important inflammatory
mediator and anti-microbial factor. Although this is a likely possibility, these in vitro
studies will have to be validated by corresponding in vivo studies. The observed
increase in total antioxidants in the iNOS KO AMs suggests that the system has
attempted to compensate for the oxidative stress. Therefore, in vivo the situation may
be resolved allowing the animals to survive. In addition, the in vitro data reported here
will aid in the planning and interpreting of future in vivo studies. The knowledge gained
through those studies in the iNOS KO mouse should further uncover the role of NO in
pulmonary inflammation.
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Figure 1- RT-PCR analysis for iNOS. Panel a- Peritoneal macrophages
harvested from WT or iNOS KO mice treated i.p. with 0.5 mg/kg LPS for 12
hours. Panel b- GAPDH to verify equal gel loading.
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Figure 2- NOx production by WT or iNOS KO primary alveolar macrophages
treated in vitro for 24 hours with IFN-γ (50 U/ml) ± LPS (1 µg/ml). * indicates a
significant difference from control (p<0.05)
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Figure 3a- TNF-α production by WT or iNOS KO primary alveolar macrophages
(105 cells/200 µl) treated in vitro with LPS for 6 hours. * indicates the
concentration- response curves are significantly different (p<0.05)
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Figure 3b- TNF-α production by WT or iNOS KO primary alveolar macrophages
(105 cells/200 µl) treated in vitro with LPS for 18 hours.
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Figure 4a- MIP-2 production by WT or iNOS KO primary alveolar macrophages
(105 cells/200 µl) treated in vitro with LPS for 6 hours. * indicates the
concentration- response curves are significantly different (p<0.05)
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Figure 4b- MIP-2 production by WT or iNOS KO primary alveolar macrophages
(105 cells/200 µl) treated in vitro with LPS for 18 hours. * indicates the
concentration- response curves are significantly different (p<0.05)
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Figure 5- Confocal images showing the basal production of H2O2 and O2 from
primary alveolar macrophages. Images are displayed in pseudocolor format
where blue indicates areas of low intensity and increasingly high intensity areas
are green<yellow<red<white.
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Figure 6a- Basal production of H2O2 from WT or iNOS KO primary alveolar
macrophages (n=50 cells for image quantification). * indicates a significant
difference between the WT and iNOS KO cells (p<0.05)
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Figure 6b- Basal production of O2 from WT or iNOS KO primary alveolar
macrophages (n=50 cells for image quantification). * indicates a significant
difference between the WT and iNOS KO cells (p<0.05)
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Figure 7- Confocal images showing silica-stimulated H2O2 and O2 production
from primary alveolar macrophages. Primary AMs from iNOS KO or WT mice
were stimulated in vitro with 100 µg/ml silica for 30 minutes. Images are
displayed in pseudocolor format where blue indicates areas of low intensity and
increasingly high intensity areas are green<yellow<red<white.
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Figure 8a- Silica-stimulated H2O2 production from WT or iNOS KO primary
alveolar macrophages (n=50 cells/treatment for image quantification). Primary
AMs from iNOS KO or WT mice were stimulated in vitro with 100 µg/ml silica for
30 minutes. Data are presented as % of control where the dashed line is
control=100%. * or + indicates a significant difference from control or between
iNOS KO and WT cells, respectively (p<0.05)
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Figure8b- Silica-stimulated O2 production from WT or iNOS KO primary alveolar
macrophages (n=50 cells/treatment for image quantification). Primary AMs from
iNOS KO or WT mice were stimulated with in vitro 100 µg/ml silica for 30
minutes. Data are presented as % control where the dashed line is
control=100%. * or + indicates a significant difference from control or between
iNOS KO and WT cells, respectively (p<0.05)
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Figure 9a- LPS-stimulated H2O2 production from WT or iNOS KO primary
alveolar macrophages (n=50 cells/treatment for image quantification). Primary
AMs from iNOS KO or WT mice were stimulated in vitro with 10 µg/ml LPS for 30
minutes. Data are presented as % control where the dashed line is
control=100%. * or + indicates a significant difference from control or between
iNOS KO and WT cells (p<0.05)
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Figure 9b- LPS-stimulated O2 production from WT or iNOS KO primary alveolar
macrophages (n=50 cells/treatment for image quantification). Primary AMs from
iNOS KO or WT mice were stimulated in vitro with 10 µg/ml LPS for 30 minutes.
Data are presented as % control where the dashed line is control=100%. * or +
indicates a significant difference from control or between iNOS KO and WT cells,
respectively (p<0.05)
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Figure 10- FACS. H2O2 production by WT primary alveolar macrophages upon
in vitro treatment with silica (100 µg/ml) for 30 minutes. Value in upper left corner
represents the mean fluorescence intensity of 8540 ± 243 events/treatment and
M1 represents the median.
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Figure 11- Basal total antioxidant capacity of 106 cells/ml from WT (n=10) or
iNOS KO (n=4) primary alveolar macrophages. * - indicates a significant
difference between WT and iNOS KO cells (p<0.05)
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FACS
H2O2
WT
Basal a
Silica b
LPS b
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322%

O2

iNOS KO
165
114%
84%

WT
34
280%
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˙-

iNOS KO
82
208%
85%
˙-

Table 1- FACS data representing the basal production of H2O2 and O2 in WT and iNOS
KO primary alveolar macrophages. a – values represented as mean fluorescence; bvalues represented as percent of control.
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STUDY 3
ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE-DERIVED NITRIC OXIDE IN
LIPOPOLYSACCHARIDE PLUS INTERFERON-γ-INDUCED PULMONARY
INFLAMMATION
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ABSTRACT
Exposure of mice to lipopolysaccharide (LPS) plus interferon-γ (IFN-γ) increases
nitric oxide (NO) production, which has been proposed to play a role in the resulting
pulmonary damage and inflammation. To determine the role of NO in this lung reaction,
the responses of inducible nitric oxide synthase knockout (iNOS KO) versus C57BL/6J
wild type (WT) mice to aspiration of LPS+IFN-γ were compared. Male mice (8-10
weeks) were exposed by aspiration to LPS (1.2 mg/kg) + IFN-γ (5000 U/mouse) or
saline vehicle. At 24 or 72 hours post-exposure, lungs were lavaged with 10 aliquots (1
ml each) of Ca+2 + Mg+2 free phosphate buffered saline. The acellular fluid from the first
bronchoalveolar lavage (BAL) was analyzed for total antioxidant capacity, lactate
dehydrogenase (LDH) activity, albumin, tumor necrosis factor-α (TNF-α) and
macrophage inflammatory protein-2 (MIP-2). The cellular fraction of the total BAL fluid
was used to determine alveolar macrophage (AM) and polymorphonuclear leukocyte
(PMN) counts, and AM zymosan-stimulated chemiluminescence (AM-CL). Pulmonary
response 24 hours after exposure to LPS + IFN-γ were characterized by significantly
decreased total antioxidant capacity, increased BAL AMs and PMNs, LDH, albumin,
TNF-α and MIP-2, and enhanced AM-CL to the same extent in both WT and iNOS KO
mice. Responses 72 hours post-exposure were similar; however, significant differences
were found between the responses of WT and iNOS KO mice. iNOS KO mice
demonstrated a greater decline in total antioxidant capacity, greater BAL PMNs, LDH,
albumin, TNF-α and MIP-2, and an enhanced AM-CL compared to the WT. These data
suggest that the role of iNOS-derived NO in the pulmonary response to LPS + IFN-γ is
anti-inflammatory, and this becomes evident over time.
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INTRODUCTION
Lipopolysaccharide (LPS), or endotoxin, is a structural component of the outer
leaflet of the outer membrane of gram-negative bacteria (Rietschel & Westphal, 1999).
Bacterial invasion into the body leads to bacteriolysis which releases these structural
components that, in turn, cause a complex immune response (Beutler &
Rietschel,2003). Particles generated from compost, grain, hay, silage, and cotton, for
example, are often contaminated with bacteria and bacterial products (Castranova et
al., 1996; Rylander, 1997). Acute inhalation of these organic particles may lead to a
respiratory disease known as organic dust toxic syndrome (ODTS). Chronic exposure
to organic particles, typically in cotton and flax processing plants, may result in the
obstructive lung disease byssinosis (Merchant et al., 1975; Rylander & Morey, 1982).
Animal and cellular studies show LPS activates alveolar macrophages (AMs),
which are the primary phagocytic cells in the lung. AM activation by LPS involves
release of tumor necrosis factor-α (TNF-α), production of chemokines which cause
polymorphonuclear leukocyte (PMN) infiltration into the alveolus, activation of nuclear
factor-kB (NF-kB) and mitogen activated protein kinase (MAPK) pathways, and
generation of reactive species (Beutler et al.,1985;Han et al.,1994;Ryan &
Karol,1991;Shakhov et al.,1990). Guinea pigs exposed to LPS-contaminated cotton
dust had increased TNF-α and PMNs in the bronchoalveolar lavage (BAL) fluid (Ryan &
Karol,1991). In addition, LPS administration in rats has been shown to increase
inducible nitric oxide synthase (iNOS or NOS2) expression and subsequent production
of nitric oxide (NO) production, nitrotyrosine, and chlorotyrosine in the lung (Huffman et
al., 1997;Hataishi et al., 2002).
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As mentioned, NO derived from iNOS is enhanced in response to LPS.
Numerous studies suggest iNOS-derived NO plays a role in inflammation, but the
pulmonary actions of NO, in response to LPS and other stimuli, remain unknown. NO
has been shown to increase proliferation of human lung fibroblasts in vitro, which
suggests NO plays a role in the development of pulmonary fibrosis (Romanska et
-

al.,2002). Highly reactive intermediates, such as peroxynitrite (OONO ) formed from
.-

NO and superoxide (O2 ), have been implicated in the pathogenesis of pneumoconiosis
(Castranova et al., 1998; Iguchi et al., 1996; Tanaka et al., 1998). In contrast, iNOSderived NO possesses anti-microbial properties as demonstrated in vivo where
protection against anthrax and Bordetella pertussis infection was observed in wild type
(WT) compared to iNOS knockout (KO) mice (Canthaboo et al., 2002; Kalns et al.,
2002). In addition, NO from exogenous sources has been reported to attenuate LPSinduced acute lung injury in rabbits (Kang et al., 2002; Uchizumi et al., 1993).
Interferon-γ (IFN- γ) is a potent inflammatory cytokine produced mainly by T
lymphocytes and natural killer cells. IFN-γ activates macrophages to release NO and
other inflammatory mediators (Beutler et al.,1985;Boehm et al.,1997;Farrar &
Schreiber,1993). Primary mouse AMs, harvested from C57BL/6J mice, show an
increase in NO production, as measured by nitrate and nitrite (NOx) release into the
cellular supernatant, after exposure to IFN-γ. LPS stimulation further increases this
NOx production (Zeidler et al., 2003). IFN-γ ± LPS-induced NOx does not occur in AMs
harvested from iNOS KO mice (Zeidler et al., 2003). LPS administered intraperitoneally
also increases iNOS mRNA in WT mice but not in iNOS KO mice (Zeidler et al., 2003).
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Therefore, the objective of this study was to determine the role of iNOS-derived
NO in a model of acute and longer-term lung inflammation. The iNOS KO and the
background strain (C57BL/6J) were exposed to a combination of LPS + IFN-γ via
aspiration. Aspiration is a method of pulmonary exposure, which results in uniform
deposition of the exposure agent (Rao et al., 2003). Pulmonary response was
evaluated at 24 and 72 hours after aspiration of LPS + IFN-γ, and lung damage and
inflammation were compared in iNOS KO and WT mice.
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METHODS
Animals- Breeder pairs of iNOS KO mice along with wild type strain (C57BL/6J)
were purchased from Jackson Laboratories (Bar Harbor, Maine). Animals were housed
in an AAALAC-accredited, specific pathogen-free, environmentally controlled facility and
allowed to acclimate at least 5 days prior to use. The mice were free of endogenous
viral pathogens, parasites, mycoplasms, Helicobacter and CAR Bacillus. Mice were
kept in ventilated cages, which were provided HEPA-filtered air, with Alpha-Dri virgin
cellulose chips and hardwood Beta-chips for bedding. Food and tap water were given
ad libitum. Male mice, 8-10 weeks old with an average body weight of 25 grams, were
used in this study.
Mouse Pharyngeal Aspiration- Mouse pharyngeal aspiration was performed as
described by Rao et al. (2003). Briefly, after anesthetization with a mixture of ketamine
and xylazine (50 and 2 mg/kg subcutaneous in the abdominal area, respectively), the
mouse was placed on a board in a near vertical position and the animal=s tongue
extended with lined forceps. A suspension (~30 µl) of LPS from E.coli serotype 026:B6
(Sigma, St.Louis, MO) at a dose of 1.2 mg/kg and a bolus dose of 5000 U/mouse
recombinant murine IFN-γ (BioSource International, Inc. Camarillo, CA) was placed
posterior in the throat and the tongue held until the suspension was aspirated into the
lungs. Control mice were administered sterile Ca+2 + Mg+2-free phosphate buffered
saline (PBS) vehicle. The mice revived unassisted after approximately 30-40 minutes.
Mice were sacrificed either 24 or 72 hours following aspiration.
Bronchoalveolar Lavage- Mice were weighed and euthanized with an
intraperitoneal injection of sodium pentobarbital (>100 mg/kg). The trachea was
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cannulated with a blunted 22 gauge needle and BAL was performed using cold sterile
Ca 2+ + Mg 2+- free PBS at a volume of 0.6 ml for first lavage (kept separate) and 1.0 ml
for subsequent lavages. Approximately 10 ml of BAL fluid per mouse were pooled and
collected in sterile centrifuge tubes. Typically, BAL fluid from 2-3 mice was pooled to
obtain a sufficient cell number for experiments. Pooled BAL cells were washed in Ca+2
+ Mg+2-free PBS by alternate centrifugation (600 x g for 10 minutes at 4º C) and
resuspension. Acellular first fraction BAL aliquots were frozen or kept on ice for later
analysis. The final cell pellet was suspended in 10mM HEPES buffer (145 mM NaCl, 5
mM KCl, 10mM HEPES, 1mM CaCl2, 5.5 mM glucose) at pH=7.4.
Cell Counts and Differentials- Cell counts were performed using an electronic
cell counter equipped with a cell sizing attachment (Coulter model Multisizer II with a
256C channelizer, Coulter Electronics, Hialeah, FL). Alveolar macrophages or
polymorphonuclear leukocytes were identified by their characteristic cell diameter
(Castranova et al., 1990).
First Bronchoalveolar Lavage Fluid Tumor Necrosis Factor-α and
Macrophage Inflammatory Protein-2 Assays- After thawing at room temperature, the
first BAL supernatants were assayed directly using a mouse TNF-α (BioSource
International, Camarillo, CA) or a mouse macrophage inflammatory protein-2 (MIP-2)
ELISA kit ( R & D Systems, Minneapolis, MN) according to manufacturers’ instructions.
Concentrations of TNF-α and MIP-2 were determined in pg/ml based on the appropriate
TNF-α or MIP-2 standard curve. ELISA plates were read at 450nm, using a
Spectramax 250 microplate spectrophotometer (Molecular Devices Corporation,
Sunnyvale, CA).
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Primary Mouse Alveolar Macrophage Zymosan-Stimulated
Chemiluminescence- Alveolar macrophage chemiluminescence was determined as
described by Porter et al. (2002), using an automated luminometer (Berthold Autolumat
LB 953, EG & G, Gaithersburg, MD) at 390-620 nm for 15 minutes with a total assay
volume of 0.25 ml. Briefly, 1.0 x 106 alveolar macrophages/ml from control or exposed
mice were incubated in HEPES buffer and resting chemiluminescence was determined
by adding 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) at a final concentration of
0.08 µg/ml. Zymosan-stimulated alveolar macrophage chemiluminescence was
determined by adding unopsonized zymosan A (Sigma, St. Louis, MO) at 2 mg/ml
immediately before measurement. Unopsonized zymosan has been shown to stimulate
chemiluminescence from alveolar macrophages but not polymorphonuclear leukocytes,
which only respond to opsonized stimulants (Allen et al., 1977; Castranova et al., 1987;
Hill et al., 1977). Zymosan-stimulated alveolar macrophage chemiluminescence was
calculated as counts per minute (cpm) in the zymosan-stimulated assay minus cpm in
the resting assay.
First Bronchoalveolar Lavage Fluid Albumin- Albumin concentration (mg/ml)
was determined colorimetrically at 628 nm based on albumin binding to bromcresol
green (Albumin BCG diagnostic kit, Sigma, St. Louis, MO) using a Cobas Mira Plus
Transfer Analyzer (Roche Diagnostic Systems, Montclair, NJ).
First Bronchoalveolar Lavage Fluid Lactate Dehydrogenase ActivityLactate dehydrogenase (LDH) activity (U/L) was determined by monitoring the LDH
catalyzed oxidation of pyruvate coupled with the reduction of NAD at 340 nm, using a
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commercial kit and a Cobas Mira Plus Transfer Analyzer (Roche Diagnostics Systems,
Montclair, NJ).
First Bronchoalveolar Lavage Fluid Total Antioxidant Capacity- Total
antioxidant capacity was assessed, using the Bioxytech AOP-490 assay (Oxis
Research, Portland, OR), which is based upon the reduction of Cu2+ to Cu+ by all
antioxidants in the sample. Using a SpectraMax 250 microplate spectrophotometer
(Molecular Devices Corporation, Sunnyvale, CA) set to 490 nm, data were obtained
from a standard curve of known uric acid concentrations and expressed as “mM Uric
Acid Equivalents.”
Statistical Analysis- Statistical significance was obtained, using a Student’s ttest with p<0.05. To achieve an adequate cell number for the experiments, BAL cells
were pooled from 2-3 mice in most cases. Therefore, the experimental n is indicative of
the number of times the experiment was repeated and not the number of mice pooled
(i.e., 2-3 mice pooled equaled an n=1).
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RESULTS
Bronchoalveolar Lavage Alveolar Macrophage Yield - Figure 1 shows the AM
yield from WT and iNOS KO mice treated with LPS + IFN-γ at 24 (Panel A) and 72
(Panel B) hours post-exposure. There was a significant increase, from the respective
control, in AMs at 24 hours which further increased at 72 hours post-exposure. There
was no significant difference in AM yield between the WT and iNOS KO under control or
LPS + IFN-γ treated conditions at 24 or 72 hours.
Bronchoalveolar Lavage Polymorphonuclear Leukocyte Yield- Figure 2 is the
PMN yield from WT and iNOS KO mice exposed to LPS + IFN-γ at 24 (panel A) and 72
(panel B) hours post-exposure. No significant difference was found between the WT
and iNOS KO control PMN counts at 24 or 72 hours. There was a significant increase,
from the respective control, in PMNs at the 24 hour timepoint for both mice. Further
increases were seen for the iNOS KO at 72 hours post-exposure. The iNOS KO had a
significantly higher PMN yield than the WT mice at this timepoint.
First Bronchoalveolar Lavage Fluid Lactate Dehydrogenase Activity- First BAL
fluid LDH activity, a measure of cytotoxicity, is shown in Figure 3. Panel A and B
represent 24 and 72 hours post-exposure, respectively. LDH was significantly
increased (approximately 50%) from the corresponding WT or iNOS KO control at 24
hours post-exposure. Further increases were observed at 72 hours (approximately
230% and 350% above the WT or iNOS KO control, respectively) with the iNOS KO
having a significantly higher cytotoxic response compared to the WT at this time point.
First Bronchoalveolar Lavage Fluid Albumin- An indicator of damage to the airblood barrier is first BAL fluid albumin concentration shown in Figure 4. Albumin was
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significantly elevated in both WT and iNOS KO mice at 24 hours (panel A) with an even
greater increase at 72 hours post-exposure (panel B). The 72 hour timepoint revealed a
significantly higher albumin concentration in the iNOS KO compared to the WT. Note:
No differences were found between the control levels of the WT and iNOS KO mice at
either timepoint.
First Bronchoalveolar Lavage Fluid Tumor Necrosis Factor-α- Concentrations of
the inflammatory cytokine TNF-α reached approximately 1690 pg/ml for both the WT
and iNOS KO mice 24 hours after LPS + IFN-γ treatment (Figure 5, panel A). At 72
hours post-exposure, TNF-α levels remained increased versus the coresponding
control, but the LPS + IFN-γ treated iNOS KO had significantly higher levels than the
WT mice (approximately 150 and 96 pg/ml, respectively). Note: Control levels of TNFα did not differ between the WT and iNOS KO mice at either timepoint. Statistical
comparisons, for the corresponding groups as percent of control, between the 24 and
72 hour timepoints, were also performed and TNF-α levels significantly decreased in
both the WT and iNOS KO mice by 72 hours (percent of control data not shown).
First Bronchoalveolar Lavage Fluid Macrophage Inflammatory Protein-2- At 24
hours post-exposure, MIP-2 levels were approximately 190 pg/ml for the WT and iNOS
KO mice compared to control values of 2-5 pg/ml (Figure 6, panel A). Again, a
significant increase was found from the corresponding WT or iNOS KO control, but not
between the WT and iNOS KO mice. At 72 hours post-exposure, levels of MIP-2 in the
first BAL had decreased toward control; however, the iNOS KO had significantly higher
MIP-2 levels compared to the WT at this timepoint (Figure 6, panel B). Note: Control
levels of MIP-2 did not differ between the WT and iNOS KO at either timepoint.
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First Bronchoalveolar Lavage Fluid Total Antioxidant Capacity- The total
antioxidant capacity of BAL fluid is represented in Figure 7 for the 24 (panel A) and 72
(panel B) hour post-exposure to LPS + IFN-γ or saline vehicle. At 24 hours postexposure, levels of antioxidants were significantly decreased to the same extent in the
WT and iNOS KO mice. At 72 hours post-exposure, levels of antioxidants had
increased toward control, but less of an increase was found in the iNOS KO, resulting in
a significant difference between the WT and iNOS KO mice. Note: Control antioxidant
capacity at 24 or 72 hours did not differ between the WT and iNOS KO mice.
Primary Mouse Alveolar Macrophage Zymosan-Stimulated ChemiluminescenceAlthough significantly elevated from the respective controls, the reactive species
production between the WT and iNOS KO AMs did not differ upon ex vivo stimulation
with zymosan 24 hours after exposure to LPS + IFN-γ in vivo (Figure 8, panel A).
Approximately, a 45 and 55 fold increase over control AM-CL was observed for the WT
and iNOS KO LPS + IFN-γ treated AMs, respectively. At 72 hours post-exposure, levels
of AM-CL had decreased in both types of mice, but were still significantly elevated from
control (panel B). At 72 hours post-exposure, the iNOS KO AMs demonstrated a
significantly enhanced reactive species production compared to the WT AMs. Note:
Control chemiluminescence did not differ at either timepoint between the WT and iNOS
KO mice. The 24 and 72 hour responses between corresponding groups were also
compared as percent of control (data not shown). The WT exhibited a significant
decline in AM-Cl at 72 hours post-exposure while the decline was not found to be
statistically significant in the iNOS KO mice.
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DISCUSSION
The present study demonstrates a strong inflammatory response is associated
with aspiration of LPS + IFN-γ in WT and iNOS KO mice. It was observed that the
response to LPS plus IFN-γ did not differ between the WT and iNOS KO mice at 24
hours post-exposure. However, at 72 hours post-exposure, significant changes
between the WT and iNOS KO response were observed for virtually all parameters in
this study. After 72 hours significantly greater inflammation and damage were evident
in the iNOS KO compared to the WT mice, suggesting an anti-inflammatory role of
iNOS-derived NO in this experimental model.
Exposure of WT and iNOS KO mice to LPS + IFN-γ significantly increased LDH
activity and albumin levels in the first BAL fluid, indicating cytotoxicity and damage to
the alveolar air/blood barrier, respectively. The cellular injury and damage caused by
aspirated LPS + IFN-γ was found to be greater at 72 hours post-exposure compared to
24 hours. Furthermore, at 72 hours post-exposure, the response in the iNOS KO mice
was more severe than for the WT.
The findings for AM-CL and total antioxidant capacity also suggest NO may play
a protective role in this experimental model. LPS + IFN-γ-induced generation of
reactive species and decrease in antioxidant capacity in the iNOS KO mice were
significantly greater than the WT at 72 hours post-exposure. This implicates NO as a
possible antioxidant engaged in attenuating lung damage induced by LPS + IFN-γ.
NO is produced, via iNOS, by AMs, alveolar type II epithelial cells, and PMNs in
response to inflammatory stimuli such as LPS and cytokines (Gutierrez et
al.,1995;Palmer et al.,1988;Salvemini et al.,1989;Wright et al.,1989). Currently, the
111

majority of data suggest NO derived from iNOS is a potent inflammatory mediator that
causes significant lung injury and damage. For example, NO and its reactive
intermediates are known to be involved in the pulmonary damage associated with
cotton dust, silica, and asbestos exposure (Chao et al.,1996;Iguchi et al.,1996;Mongan
et al.,2000;Porter et al.,2002;Thomas et al.,1994). Lung injury and damage during
inflammation has been associated with excess production by lung cells, including AMs
.-

-

.

and PMNs, of reactive species, such as NO and O2 which may form OONO , OH ,
H2O2, as well as other inflammatory mediators. Thus, iNOS KO mice would be
expected to exhibit less injury and damage due to the lack of production of certain
reactive species. This study indicates an alternative, perhaps protective, action of NO
may exist during pulmonary exposure to the gram-negative bacteria derivative LPS and
the inflammatory cytokine IFN-γ.
Studies show NO may act to counteract oxidative lung injury by decreasing the
reactivity of lipid radicals and the extent of lipid peroxidation (Rubbo et al.,1994). It has
also been shown that exogenous and endogenous NO attenuates leukocyte adhesion
and sequestration into the lung, both in vivo after i.v. endotoxin administration and in
vitro, decreasing the overall lung inflammatory mileu (Gaston et al.,1994;Hickey &
Kubes,1997;Lin et al.,2001;Sato et al.,1999). Evidence for the protective actions of NO
in the lung during certain inflammatory states have previously been reported. For
example, acute lung injury induced by ozone or hyperoxia resulted in significantly
greater lung injury and damage, as measured by total protein, LDH, albumin, and PMNs
in the BAL fluid, in iNOS KO compared to WT mice (Kenyon et al.,2002;Kobayashi et
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al.,2001). The present study also reported a similar protective action of NO in response
to LPS + IFN-γ-induced inflammation, as mentioned above.
Both TNF-α and MIP-2 levels in the first BALF were significantly greater in the
iNOS KO compared to the WT mice at 72 hours post-exposure to LPS + IFN-γ, although
levels had decreased in both groups from 24 hours post-exposure. TNF-α and MIP-2
are central to the prompt initiation and progression of the lung inflammatory response.
TNF-α release causes PMN influx, vascular endothelial adhesion molecule expression,
and release of inflammatory mediators from multiple pulmonary cell types (Albelda et
al.,1994;Springer,1994;Standiford et al.,1990;Strieter et al.,1989). MIP-2 is a potent
chemoattractant factor for PMNs and the heightened levels of MIP-2 in the iNOS KO
mice versus WT coincide with the greater PMN yield observed at 72 hours postexposure. This observation was also reported by Kenyon et al. (2002) in a model of
ozone-induced acute lung injury in iNOS KO mice.
NF-κB activation is associated with the production of TNF-α and MIP-2 and when
inhibited, LPS induction of these inflammatory mediators decreases (Raychaudhuri et
al.,1999). An action recently proposed for NO is the inhibition of this transcription factor.
Data show that NO increases the levels of the inhibitory subunit IκBα and decreases
NF-κB binding to gene promoter regions in the DNA by nitrosylating cysteine residues
on the p50 subunit of this transcription factor (Matthews et al.,1996;Peng et al.,1995).
In vivo, exogenous NO (10 ppm) has been reported to attenuate pulmonary damage
and inflammation in rabbits exposed to intravenous LPS through suppression of NF-κB
(Kang et al.,2002).
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Surprisingly, this study demonstrated lack of a vital role for iNOS-derived NO in
the immediate inflammatory response (i.e. 24 hours) to LPS + IFN-γ. However, after 72
hours the differences in the WT and iNOS KO mice became apparent, suggesting NO
plays a more pronounced role in lung inflammation and damage after the initial phase.
An explanation for this may be that the initial and extended responses to aspirated LPS
+ IFN-γ differ. All parameters significantly increased from the respective controls in
response to LPS + IFN-γ, except total antioxidant capacity which showed a significant
decline, in the 24 hour phase of the experiment. Typically, after initial injury, there is
resolution of the inflammation and damage, but this was not observed in the present
study for all parameters at 72 hours post-exposure. For example, AMs, PMNs (only in
the iNOS KO), LDH, and albumin continued to increase 72 hours post-exposure to LPS
+ IFN-γ. In contrast, TNF-α, MIP-2 and AM-CL declined, while total antioxidants in the
first BAL increased toward control, from 24 to 72 hours. As mentioned, the iNOS KO
mice showed significantly greater changes in these parameters at 72 hours postexposure. Therefore, the extended response in terms of cellular influx, cytotoxicity, and
blood air-barrier damage (most likely due to increased inflammatory cell influx)
worsened but cellular activity (measured as cytokines and reactive species production)
and antioxidant status were recovering.
It is possible that the protective action of NO at 72 but not 24 hours postexposure reflects the time course of NO production following LPS + IFN-γ treatment.
The source of NO pertinent in this study results from transcription and translation of
inducible NOS, which takes adequate time to complete possibly allowing differences
only to be seen after a sufficient induction time. Reports show that iNOS mRNA is
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detectable in rats approximately 4 hours after stimulation with LPS and significant NO
production is observed after about 8 hours (Castranova et al., 1998). At present, the
time course of NO induction in the mouse has not been fully investigated, so the
question remains unresolved although, during hyperoxia, iNOS mRNA in C57BL/6J
mice was reported to be expressed between 24 and 72 hours post-exposure
(Kobayashi et al.,2001).
In summary, NO may not always cause lung damage and inflammation. The
present study revealed protective (i.e. anti-inflammatory) effects of NO derived from
iNOS, i.e., the absence of NO in iNOS KO mice enhanced pulmonary inflammation and
damage in response to LPS + IFN-γ exposure. These effects were observed at 72
hours post-exposure but not after 24 hours, which suggests the effects of iNOS may be
more prominent in the later phases of disease progression. The reported findings are
consistent with a select group of models of acute lung injury that also suggest lung
inflammatory responses may be mitigated by iNOS-derived NO.
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Figure 1- Alveolar macrophage yield per mouse measured 24 (panel A) and 72 (panel
B) hours after exposure to LPS + IFN-γ or saline vehicle. a-indicates a significant
increase from the corresponding control alveolar macrophage yield at 24 or 72 hours
(p<0.05).
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Figure 2- Polymorphonuclear leukocyte yield per mouse measured 24 (panel A) and 72
(panel B) hours after exposure to LPS + IFN-γ or saline vehicle. a - indicates a
significant increase from the corresponding control polymorphonuclear leukocyte yield;
b - indicates a significant difference between the iNOS KO and WT treated groups
(p<0.05).
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Figure 3- First bronchoalveolar lavage lactate dehydrogenase activity measured 24
(panel A) and 72 (panel B) hours after exposure to LPS + IFN-γ or saline vehicle. Data
are presented as percent of control (dashed line indicating 100%). a - indicates a
significant increase from the corresponding control lactate dehydrogenase activity; b indicates a significant difference between the iNOS KO and WT treated groups; *indicates a significant difference between the 24 and 72 hour corresponding treated
groups (p<0.05).
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Figure 4- First bronchoalveolar lavage fluid albumin measured 24 (panel A) and 72
(panel B) hours after exposure to LPS + IFN-γ or saline vehicle. Data are presented as
percent of control (dashed line indicating 100%). a - indicates a significant increase
from the corresponding control albumin levels; b - indicates a significant difference
between the iNOS KO and WT treated groups; *- indicates a significant difference
between the 24 and 72 hour corresponding treated groups (p<0.05).
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Figure 5- First bronchoalveolar lavage fluid TNF-α measured 24 (panel A) and 72
(panel B) hours after exposure to LPS + IFN-γ or saline vehicle. a - indicates a
significant increase from the corresponding control TNF-α levels; b - indicates a
significant difference between the iNOS KO and WT treated groups.
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Figure 6- First bronchoalveolar lavage fluid MIP-2 measured 24 (panel A) and 72 (panel
B) hours after exposure to LPS + IFN-γ or saline vehicle. Data are presented as
percent of control (dashed line indicating 100%). a - indicates a significant increase
from the corresponding control MIP-2 levels; b - indicates a significant difference
between the iNOS KO and WT treated groups; *- indicates a significant difference
between the 24 and 72 hour corresponding treated groups (p<0.05).
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Figure 7- First bronchoalveolar lavage fluid total antioxidant capacity measured 24
(panel A) and 72 (panel B) hours after exposure to LPS + IFN-γ or saline vehicle. a indicates a significant decrease from the corresponding control total antioxidant
capacity; b - indicates a significant difference between the iNOS KO and WT treated
groups at 24 or 72 hours (p<0.05).
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Figure 8- Zymosan-stimulated alveolar macrophage chemiluminescence measured 24
(panel A) and 72 (panel B) hours after exposure to LPS + IFN-γ or saline vehicle. a indicates a significant increase from the corresponding control zymosan-stimulated
chemiluminescence; b - indicates a significant difference between the iNOS KO and WT
treated groups at 24 or 72 hours.
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STUDY 4
ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE-DERIVED NITRIC OXIDE IN
SILICA-INDUCED PULMONARY INFLAMMATION AND FIBROSIS
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ABSTRACT
Studies have shown that inhalation of α-quartz (crystalline silica) can cause lung
inflammation, damage, and fibrosis in humans. Nitric oxide (NO), derived from the
inducible nitric oxide synthase (iNOS), is believed to be involved in silica-induced lung
disease. However, the role of NO remains controversial with both anti- and proinflammatory actions reported. To determine the role of iNOS derived NO in silicainduced lung disease, the responses of iNOS knockout (KO) versus C57BL/6J wild type
(WT) mice to quartz were compared. Male mice (8-10 weeks) were exposed by
aspiration to silica (40 mg/kg) or saline vehicle. At 24 hours and 42 days postexposure, lungs were lavaged with 10 aliquots (1 ml each) of Ca+2 + Mg+2 free
phosphate-buffered saline. The supernatant from the first bronchoalveolar lavage (BAL)
was analyzed for markers of lung injury [lactate dehydrogenase (LDH) activity and
albumin], for inflammatory cytokines [tumor necrosis factor-α (TNF-α) and macrophage
inflammatory protein-2 (MIP-2)], and for total antioxidant capacity. The cellular fraction
of the total BAL was used to determine alveolar macrophage (AM) and
polymorphonuclear leukocyte (PMN) counts, and zymosan-stimulated AM
chemiluminescence (AM-CL), a measure of AM reactive species production. In
separate experiments, whole lungs were excised, weighed, sectioned, and stained to
observe lung histopathological changes after 42 days. Acute (24 hour) silica exposure
significantly decreased AM yield, increased PMNs, LDH, albumin, TNF-α and MIP-2,
and enhanced AM-CL in iNOS KO and WT mice. However, iNOS KO mice exhibited
significantly less AM activation (defined as an increased AM-CL and decreased AM
yield) than WT mice. In addition, total antioxidant capacity following acute silica
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exposure decreased in WT but was maintained in the iNOS KO mice. Responses to
sub-chronic (42 days) silica exposure were similar to acute pulmonary reactions.
However, LDH, albumin, and TNF-α were elevated to a greater extent in WT mice.
Histopathology indicated alveolar lipoproteinosis and alveolitis was significantly less in
the iNOS KO versus WT mice. These data implicate that iNOS-derived NO plays a role
in the pathogenesis of silica-induced lung disease.
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INTRODUCTION
Inhalation of crystalline silica in various occupational settings, including
sandblasting, quarrying, stone dressing, refractory manufacture, or foundry work, can
result in silicosis (Mossman & Churg,1998). Various clinical and pathological forms of
the disease exist including acute, accelerated and chronic silicosis, which depend on
the level of dust exposure and the resulting latency period for disease initiation and
progression.
Silica occurs naturally either in noncrystalline (amorphous) or crystalline forms.
Crystalline silica, as compared to amorphous varieties, is known to be more pathogenic
in humans and is composed of silicon and oxygen (SiO2) with trace quantities of Al, Fe,
Mn, Mg, Ca, and Na (Mossman & Churg,1998). α-Quartz, used in the present study, is
the most common form of crystalline silica. This particular form comprises nearly 67%
of granite, shale, and sandstone; thus, significant exposure can occur in occupations
that involve blasting, grinding, or fracturing of these rocks (Mossman & Churg,1998).
Reactive species produced either by silica or silica-stimulated cells are proposed
to be mediators of silica-induced inflammation, cytotoxicity, DNA modifications, and
fibrosis (Daniel et al.,1993;Mossman & Churg,1998;Shukla et al.,2001;Vallyathan et
al.,1998). Nitric oxide (NO) is a reactive nitrogen species recently implicated in the
pathogenesis of silica-induced lung disease. NO is formed from the conversion of the
amino acid L-arginine to L-citrulline in the presence of various cofactors and the enzyme
nitric oxide synthase (NOS). There are three described isoforms of NOS, inducible
NOS (iNOS or NOS2), and the constitutive NOS isoforms endothelial (eNOS or NOS3)
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or neuronal (nNOS or NOS1). iNOS is produced in various lung cells in response to
inflammatory stimuli, such as endotoxin (Mikawa et al.,1998).
The role of iNOS-derived NO in particle-induced lung disease remains unclear
with both anti-inflammatory and pro-inflammatory mechanisms being described.
Conflicting data show NO may inhibit or enhance the activation of nuclear factor-κB
(NF-κB), which ultimately effects the production of inflammatory cytokines (Chen et
al.,1995a;Kang et al.,2000b). NO also increases lung inflammation and damage by
.-

combining with superoxide (O2 ) to form peroxynitrite (OONO-), a highly reactive
species that causes lipid peroxidation, mitochondrial and DNA damage, as well as
enzyme and protein inactivation (Haddad et al.,1996a;Haddad et al.,1996b;Hogg &
Kalyanaraman,1999;van der Vliet et al.,1997).
Intratracheal instillation and inhalation exposures in rats show increased NO
production is associated with the lung injury caused by silica. (Blackford et al.,1997)
reported that iNOS mRNA induction in bronchoalveolar lavage (BAL) cells and NOdependent chemiluminescence from alveolar macrophages (AMs) correlated with the
degree of pulmonary inflammation caused by intratracheal instillation of rats with silica,
coal, carbonyl iron, or titanium dioxide. Furthermore, a chronic rat silica inhalation study
by Porter et al. (2002) showed a temporal correlation between lung NO production and
pulmonary inflammation and fibrosis. Immunohistochemistry data also revealed that
silicotic lesions in the lung were associated with iNOS staining and nitrotyrosine
residues. In humans, Castranova et al. (1998) reported that AMs harvested from coalminers exposed chronically to silica-containing dusts had enhanced NO-dependent
chemiluminescence and iNOS mRNA induction compared to AMs from a healthy non133

smoking subject, with NO induction associated with disease progression determined by
chest radiographs.
Therefore, based on the evidence presented thus far, iNOS-derived NO appears
to assume a predominately detrimental role in silica-induced lung disease. A model of
iNOS-derived NO deficiency, the iNOS knockout mouse (iNOS KO), has recently been
employed in studies involving endotoxin, asbestos, and silica to further examine the role
of this inflammatory mediator. Intratracheal instillation of asbestos in iNOS KO mice, for
example, resulted in an enhanced pulmonary inflammatory response [higher tumor
necrosis factor-α (TNF-α) production and neutrophil influx] but attenuated oxidantpromoted lung tissue damage as measured by decreased protein leakage and lactate
dehydrogenase (LDH) release into the alveolar space (Dorger et al.,2002).

In addition,

attenuation of silica-induced lung disease in iNOS KO mice was reported in a
histological study by Srivastava et al. (2002). The present study will further investigate
iNOS-derived NO in a model of silica-induced pulmonary damage, inflammation and
fibrosis by comparing the acute (24 hour) and sub-chronic (42 day) pulmonary
responses in wild type (WT) versus iNOS KO mice.
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METHODS
Animals- Breeder pairs of iNOS knockout mice along with wild type strain
(C57BL/6J) were purchased from Jackson Laboratories (Bar Harbor, Maine). Animals
were housed in an AAALAC-accredited, specific pathogen-free, environmentally
controlled facility and allowed to acclimate at least 5 days prior to use. The mice were
free of endogenous viral pathogens, parasites, mycoplasms, Helicobacter and CAR
Bacillus. Mice were kept in ventilated cages, which were provided HEPA-filtered air,
with Alpha-Dri virgin cellulose chips and hardwood Beta-chips for bedding. Food and
tap water were given ad libitum.
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Mouse Pharyngeal Aspiration- Mouse pharyngeal aspiration was performed as
described by Rao et al. (2003). Briefly, after anesthetization with a mixture of ketamine
and xylazine (50 and 2 mg/kg subcutaneous in the abdominal area, respectively), the
animals were placed on a board in a near vertical position and the animal=s tongue
extended with lined forceps. A suspension (~30 µl) of heat-sterilized aged Min-U-Sil 5
silica (98.5% crystalline silica, particle diameter < 5µm, US Silica, Berkeley Springs,
WV, USA) at a dose of 40 mg/kg was placed posterior in the throat and the tongue held
until the suspension was aspirated into the lungs. Control mice were administered
sterile Ca+2 + Mg+2-free phosphate buffered saline (PBS) vehicle. The mice revived
unassisted after approximately 30-40 minutes. Mice were sacrificed either 24 hours or
42 days following aspiration. Rao et al. (2003) has shown that the pharyngeal
aspiration technique results in a uniform deposition of particles throughout the mouse
lung.
Bronchoalveolar Lavage- Mice were weighed and euthanized with an
intraperitoneal injection of sodium pentobarbital (>100 mg/kg). The trachea was
cannulated with a blunted 22 gauge needle and bronchoalveolar lavage (BAL) was
performed using cold sterile Ca 2+ + Mg 2+- free PBS at a volume of 0.6 ml for first
lavage (kept separate) and 1.0 ml for subsequent lavages. Approximately 10 ml of BAL
fluid per mouse were pooled and collected in sterile centrifuge tubes. Typically, BAL
fluid from 2-3 mice was pooled to obtain a sufficient cell number for experiments.
Pooled BAL cells were washed in PBS by alternate centrifugation (600 x g for 10
minutes at 4º C) and resuspension. Acellular first fraction BAL aliquots were frozen or
kept on ice for later analysis. The final cell pellet was suspended in 10mM HEPES
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buffer (145 mM NaCl, 5 mM KCl, 10mM HEPES, 1mM CaCl2, 5.5 mM glucose) at
pH=7.4.
Cell Counts and Differentials- Cell counts were performed using an electronic
cell counter equipped with a cell sizing attachment (Coulter model Multisizer II with a
256C channelizer, Coulter Electronics, Hialeah, FL.). Alveolar macrophages or
polymorphonuclear leukocytes were identified by their characteristic cell diameter
(Castranova et al., 1990).
First Bronchoalveolar Lavage Tumor Necrosis Factor-α, Macrophage
Inflammatory Protein-2, and Transforming Growth Factor-β Assays - First BAL fluid
was assayed using a mouse TNF-α, a multispecies transforming growth factor-β (TGFβ), (BioSource International, Camarillo, CA) or a mouse macrophage inflammatory
protein-2 (MIP-2) ELISA kit (R & D Systems, Minneapolis, MN) according to
manufacturers’ instructions. First BAL fluid was diluted 1.9 fold in the TGF-β assay and
the TNF-α and MIP-2 assays required undiluted first BAL fluid. Concentrations of TNFα, TGF-β, and MIP-2 were determined as pg/ml based on the appropriate standard
curve. ELISA plates were read at 450nm using a Spectramax 250 microplate
spectrophotometer (Molecular Devices Corporation, Sunnyvale, CA).
Primary Mouse Alveolar Macrophage Zymosan-Stimulated
Chemiluminescence- Alveolar macrophage chemiluminescence was determined as
described by Porter et al. (2002) using an automated luminometer (Berthold Autolumat
LB 953, EG & G, Gaithersburg, MD) at 390-620 nm for 15 minutes with a total assay
volume of 0.25 ml. Briefly, 1.0 x 106 alveolar macrophages/ml from control or silicaexposed mice were incubated in HEPES buffer and resting chemiluminescence was
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determined by adding 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) at a final
concentration of 0.08 µg/ml. Zymosan-stimulated chemiluminescence was determined
by adding unopsonized zymosan A (Sigma, St. Louis, MO) at 2 mg/ml immediately
before measurement. Unopsonized zymosan has been shown to stimulate
chemiluminescence from alveolar macrophages but not polymorphonuclear leukocytes
which only respond to opsonized particles (Allen,1977;Hill et al.,1977). Zymosanstimulated chemiluminescence was calculated as counts per minute (cpm) in the
zymosan-stimulated assay minus cpm in the resting assay.
First Bronchoalveolar Lavage Fluid Albumin- Albumin concentration (mg/ml)
was determined colorimetrically at 628 nm based on albumin binding to bromcresol
green (Albumin BCG diagnostic kit, Sigma, St. Louis, MO) using a Cobas Mira Plus
Transfer Analyzer (Roche Diagnostic Systems, Montclair, NJ).
First Bronchoalveolar Lavage Fluid Lactate Dehydrogenase- LDH (U/L)
activity was determined by monitoring the LDH catalyzed oxidation of pyruvate coupled
with the reduction of NAD at 340 nm using a commercial kit and a Cobas Mira Plus
Transfer Analyzer (Roche Diagnostics Systems, Montclair, NJ).
First Bronchoalveolar Lavage Fluid Total Antioxidant Capacity- Total
antioxidant capacity was assessed using the Bioxytech AOP-490 assay (Oxis
Research, Portland, OR), which is based upon the reduction of Cu2+ to Cu+ by all
antioxidants in the sample. Using a SpectraMax 250 microplate spectrophotometer
(Molecular Devices Corporation, Sunnyvale, CA) set to 490 nm, data were obtained
from a standard curve of known uric acid concentrations and expressed as “mM Uric
Acid Equivalents.”
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Determination of NOx: Nitrate (NO3-) and Nitrite (NO2-)- AMs (2 x 105
cells/well) from WT mice exposed to silica or saline in vivo for 42 days were plated in a
24 well tissue culture plate and allowed to adhere for 90 minutes at 37°C. The wells
were washed three times to remove non-adherent cells. Cells were incubated for an
additional 18 hours and after centrifugation, the acellular supernatants were harvested
and NOx determined by flow injection analysis colorimetry at 540 nm, using the Griess
reaction (Quick-Chem 8000, Lachat Instruments, Milwaukee, WI) as described by Porter
et al. (2002).
Lung Hydroxyproline- Mice were euthanized using sodium pentobarbitol i.p. (>
100 mg/kg) at 42 days post-exposure. Lungs were removed en bloc, weighed, and
snap frozen in liquid nitrogen then frozen at –80 °C for later analysis. Lung tissue was
processed to determine hydroxyproline, according to previously described methods
(Kivirikko et al.,1967;Ma et al.,1999). Briefly, lungs were finely minced and placed in
individual capped glass test tubes with 1.0 ml of 6N HCL. Lungs were acid digested for
two days at 110 °C. Samples were centrifuged (500 x g) for one hour and the
hydrolysate was neutralized to pH=7 using KOH, and brought to a final volume of 3.7 ml
in deionized H2O. In capped glass test tubes, 0.3 ml of hydrolysate was added to 2.2 ml
borate-alanine buffer (2:1 ratio of potassium borate buffer [12.37 g boric acid and 45 g
KCL in 200 ml deionized H2O, pH=8.7] and alanine solution [10 g alanine in 100 ml
deionized H2O), pH=8.7]). Saturating amounts of solid KCL were added to samples and
hydroxyproline standards (standard range 0-28 µg) followed by 0.6 ml of 0.2 M
chloramine T (2.254 g in 40 ml ethylene glycol monomethyl ether). After oxidation at
room temperature for 40 minutes, 2 ml of 3.6 M Na2S2O3 was used to stop oxidation.
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After addition of 2.5 ml of toluene, samples were placed in a boiling water bath for 30
minutes, then centrifuged (500 x g) for 10 minutes. The organic phase (1.0 ml) was
placed in glass tubes and 0.6 ml of Ehrlich’s reagent (1:1 ratio of [2.74 ml of 10N H2SO4
in 20 ml of 200 proof ethyl alcohol] and [1.2 g of p-dimethylaminobenzaldehyde in 20 ml
200 proof ethyl alcohol]) was added followed by immediate vortexing. After standing at
room temperature for 40 minutes, samples were read on a Shimadzu UV-VIS Recording
Spectrophotometer (Shimadzu Scientific Instruments, Columbia, MD) at 560 nm against
a blank. Hydroxyproline was quantitated from the standard curve and expressed as
total hydroxyproline per lung (µg hydroxyproline detected multiplied by 11).
Lung Histopathology- Lung histopathology was performed as described by
(Hubbs et al.,2002). Briefly, mice were weighed and euthanized with an intraperitoneal
injection of sodium pentobarbital (>100 mg/kg). The abdominal aorta was transected for
exsanguination. The lungs were removed and weighed (lung wet weight). Whole lungs
were inflated with 1.0 ml of 10% neutral buffered formalin. Tissues were trimmed the
same day – sections of the left and right lung lobes were submitted whole, and the
tracheobronchial lymph node, if found, was trimmed. Tissues were processed overnight
and embedded the following day in paraffin. Slides were stained with hematoxylin and
eosin (H & E) and Masson’s trichrome. All slides were interpreted blindly by a boardcertified veterinary pathologist. Pathology scores were the sum of the distribution
(0=none, 1=focal, 2=locally extensive, 3=multifocal, 4=multifocal and coalescent,
5=diffuse) and severity scores (0=none, 1=minimal, 2=mild, 3=moderate, 4=marked,
5=diffuse) as previously described by (Hubbs et al.,1997).
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Statistical Analysis- Statistical significance was obtained using a Student’s ttest with p<0.05. In the cases where cells were pooled from multiple mice, the n is
indicative of the number of times the experiment was repeated and not the number of
mice pooled (i.e., 2-3 mice pooled equaled an n=1).
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RESULTS
Bronchoalveolar Lavage Alveolar Macrophage Yield - Figure 1 shows the AM
yield from WT and iNOS KO mice exposed to silica for 24 hours (Panel A) and 42 days
(Panel B). There was a significant decrease, from the respective control, in number of
AMs harvested by bronchoalveolar lavage at 24 hours post-exposure. AM yield
returned to control levels at 42 days post-exposure. There was a significant difference
between the WT and iNOS KO silica-treated AM yield at 24 hours but not 42 days postexposure. Note: No differences were found between the WT and iNOS KO control AM
yields at 24 hours or 42 days after exposure to saline.
Bronchoalveolar Lavage Polymorphonuclear Leukocyte Yield- Figure 2
represents the PMN yield from WT and iNOS KO mice 24 hours (panel A) and 42 days
(panel B) post-exposure. After exposure to silica, there was a significant increase, from
the respective control, in PMNs at 24 hours for the WT and iNOS KO. At 42 days postexposure to silica, further increases in PMNs were evident for the WT and iNOS KO
mice. Note: No significant difference was found between the WT and iNOS KO PMN
counts at 24 hours or 42 days from either control or silica-exposed mice.
First Bronchoalveolar Lavage Fluid Lactate Dehydrogenase- First BAL fluid LDH
activity, a measure of cytotoxicity, is shown in Figure 3. Panel A and B represent 24
hours and 42 days post-exposure to silica, respectively. LDH was significantly
increased from the corresponding WT or iNOS KO control at 24 hours post-exposure to
silica, approximately 80 U/L to 132.1 ± 5.4 and 142.4 ± 13.9 U/L, respectively. At 42
days post-exposure, silica-induced cytotoxicity in the WT and iNOS KO remained
significantly elevated from the respective control. The iNOS KO mice, however,
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exhibited significantly less silica-induced cytotoxicity as compared to WT mice. Note:
No significant difference was found between the WT and iNOS KO control levels at 24
hours or 42 days.
First Bronchoalveolar Lavage Fluid Albumin- An indicator of damage to the airblood barrier is first BAL fluid albumin concentration (Figure 4). Albumin was
significantly increased by silica exposure, to the same extent, in both WT and iNOS KO
mice at 24 hours (panel A), values of 0.24 ± 0.03 mg/ml for both groups. By 42 days
post-exposure, less silica-induced air-blood barrier damage was observed in both the
WT and iNOS KO (panel B). Although values remained significantly elevated from
control, the iNOS KO mice exhibited a more marked attenuation of air-blood barrier
damage by 42 days in comparison to the WT. Note: No differences were found
between the control states at either 24 hours or 42 days. In addition, respective control
levels did not differ at either 24 hours or 42 days between the WT or iNOS KO.
Lung wet weight- Figure 5 represents the whole lung wet weight (indicative of
pulmonary edema and/or increased matrix proteins) at 42 days after exposure to silica.
Greater pulmonary mass was found in the WT mice as shown by a significant increase
from control lung wet weight, i.e., increasing from 0.233 to 0.284 grams. A significant
increase from control was not observed in the iNOS KO mice. No difference was found
between the WT and iNOS KO control or silica-exposed lung weights.
First Bronchoalveolar Lavage Fluid Tumor Necrosis Factor-α- Concentrations of
the inflammatory cytokine TNF-α were significantly increased from control levels in the
WT and iNOS KO mice at 24 hours after silica exposure, from approximately 17 pg/ml
to 71.9 ± 3.8 and 90.0 ± 9.1 pg/ml, respectively (Figure 6, panel A). By 42 days after
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silica exposure (panel B), TNF-α levels had decreased when analyzed as a % of control
(data not shown). However, silica-induced TNF-α levels at 42 day post-exposure
remained significantly elevated from control in the WT but not in the iNOS KO mice.
Note: Control levels of TNF-α did not differ between the WT and iNOS KO at either
timepoint.
First Bronchoalveolar Lavage Fluid Macrophage Inflammatory Protein-2- At 24
hours post-exposure to silica, MIP-2 levels were increased to 28.1 ± 3.4 and 42.6 ± 9.1
pg/ml for the WT and iNOS KO mice, respectively (Figure 7, panel A). Again, a
significant increase was found between the silica-exposed and the corresponding WT or
iNOS KO control but not between the WT and iNOS KO mice. At 42 days postexposure to silica, levels of MIP-2 in the first BAL remained significantly elevated from
the respective controls and again did not differ between the WT and iNOS KO (panel B)
mice. Note: Control levels of MIP-2 did not differ between the WT and iNOS KO at 24
hours or 42 days. From 24 hours to 42 days post-exposure to silica, levels of MIP-2 did
not significantly change in the WT; however, levels significantly decreased in the iNOS
KO mice.
First Bronchoalveolar Lavage Fluid Total Antioxidant Capacity- The total
antioxidant capacity is represented in Figure 8 for the 24 hour (panel A) and 42 day
(panel B) timepoints. At 24 hours and 42 days post-exposure to silica, levels of
antioxidants were significantly decreased in the WT but were maintained in the iNOS
KO mice. Note: Control total antioxidant capacity at 24 hours or 42 days did not differ
between the mice.
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Basal NOx Production by WT Alveolar Macrophages Ex Vivo: Nitrate (NO3-) and
Nitrite (NO2-)- At the 42 day timepoint, silica-exposed WT AMs had increased basally
produced NOx concentrations, approximately 5 fold over the control AMs (data not
shown). AMs harvested from WT mice 24 hours post-exposure to silica did not exhibit
an increase in basal NOx production compared to saline control (data not shown). We
have shown previously that phagocytes from iNOS KO mice do not produce NO in
response to various stimulants (Zeidler et al.,2003).
Primary Mouse Alveolar Macrophage Zymosan-Stimulated ChemiluminescenceThe reactive species production of the iNOS KO AMs, previously exposed to silica in
vivo, was significantly less than the WT upon ex vivo stimulation with zymosan at 24
hours and 42 days post-exposure (Figure 9, panel A). At 24 hours post-exposure, the
WT AMs exhibited approximately a 2.5 fold higher zymosan-stimulated AM-CL
compared to the iNOS KO AMs. At 42 days, levels of AM-CL had decreased in both
types of mice but were still significantly elevated from the respective controls (WT AMs
exhibited approximately a 2 fold higher AM-CL compared to iNOS KO AMs) (panel B).
Note: Control AM-CL did not differ at either timepoint between the WT and iNOS KO.
First Bronchoalveolar Lavage Fluid Transforming Growth Factor- At 42 days
post-silica exposure, TGF-β levels in the first BAL fluid were approximately 254.0 ± 21.2
and 248.3 ± 15.4 pg/ml for the WT and iNOS KO mice, respectively (Figure 10). A
significant increase was found from the corresponding WT or iNOS KO control but not
between the WT and iNOS KO mice. Note: Control levels of TGF-β did not differ
between the WT and iNOS KO at 42 days.
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Whole Lung Hydroxyproline- Lung hydroxyproline was assessed to determine
pulmonary fibrosis at 42 day post-exposure to silica in the WT and iNOS KO mice
(Figure 11). It was found that the WT exhibited significant pulmonary fibrosis compared
to control (approximately 26% over control) and compared to the iNOS KO
(approximately 3% over control).
Lung Histopathology- Table 1 represents the histopathology scores for the WT
and iNOS KO mice at 42 days post-exposure to silica. Representative lung tissue
sections, stained with H&E, are shown in Figure 12. Silica exposure increased
histological evidence for alveolitis and lipoproteinosis from saline control levels.
Statistically significant differences were found between the WT and iNOS KO mice for
the severity and distribution of alveolitis and lipoproteinosis. Silica exposure resulted in
approximately 50% less alveolitis and lipoproteinosis in the iNOS KO mice compared to
the WT mice after 42 days.
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DISCUSSION
The objective of this study focused on NO derived from iNOS and its role in the
acute and sub-chronic response to silica in iNOS KO and WT (C57BL/6J - background
strain) mice. It was observed that iNOS KO mice exhibited lower AM-CL and a
maintained total antioxidant capacity compared to WT mice at 24 hours post-exposure
to silica. At 42 days post-silica exposure, iNOS KO mice exhibited less pulmonary
damage, oxidative stress (lower AM-CL and maintained antioxidant capacity) and TNFα production than WT mice. In addition, markers of lung fibrosis and histopathological
data revealed an attenuated sub-chronic response to silica in the iNOS KO mice,
suggesting iNOS-derived NO assumes a deleterious role in this experimental model.
Following acute exposure to silica, AM yield in the iNOS KO mice differed
significantly from the WT mice. It has been reported that lavageable AMs may
decrease following acute exposure to certain occupational dusts due to AM activation
and increased adherence to the alveolar wall (Castranova et al., 1987). Therefore, the
stronger adherence to the alveolus makes recovery by BAL difficult, resulting in a lower
yield, implying a higher AM activation status (Castranova et al., 1987). The present
study observed higher lavageable AMs in the iNOS KO mice, compared to the WT 24
hours after silica exposure.

By 42 days post-silica exposure, AMs harvested from the

WT and iNOS KO mice had returned to control levels and these yields (control or
treated) were not different between the two types of mice. Histologically, increased
rather than decreased numbers of phagocytic cells (including AMs) were evident in the
alveolar space of both the WT and iNOS KO lungs versus control lungs. Thus, BAL
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recovery only serves as an indicator of the in vivo situation and should not be
considered solely.
As mentioned above, the AM yield data implicated a lower silica-induced
activation status of the iNOS KO AMs, and this was further supported by a decreased
zymosan stimulated AM-CL compared to the WT AMs at both 24 hours and 42 days
post-exposure to silica. Furthermore, total antioxidant capacity in the first BAL, a nonspecific measure of antioxidants from all pulmonary cell types, was maintained after
silica exposure in the iNOS KO but significantly decreased from control in silicaexposed WT mice at both timepoints. Considered together, lower AM-CL and
maintenance of total antioxidant capacity indicates a lower silica-induced lung oxidant
burden in the iNOS KO mice.
The data show that the absence of iNOS-derived NO did not affect the levels of
the TNF-α and MIP-2 in the first BAL fluid following acute silica exposure, i.e. both the
WT and iNOS KO mice had equally elevated levels of these inflammatory mediators
versus the respective control. At 42 days post-exposure to silica, however, TNF-α
remained elevated versus control in the WT but not in the iNOS KO mice. It has been
reported that silica-induced reactive species, including NO, may regulate TNF-α gene
expression possibly through the transcription factor, NF-κB (Baeuerle,1991;DeForge et
al.,1993;Gossart et al.,1996;Rojanasakul et al.,1997;Savici et al.,1994). TNF-α is an
important pro-inflammatory cytokine that has been implicated in the initiation and extent
of pulmonary fibrosis (Piguet & Vesin,1994). The present study supports the notion that
silica-induced oxidant stress may influence NF-κB activation and subsequent TNF-α
production, and that NO plays a role in this oxidant stress.
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PMNs were increased equally by exposure to silica in both the WT and iNOS KO
mice after 24 hours. Silica-induced PMNs further increased by 42 days. This correlates
with the equally increased MIP-2 levels in WT and iNOS KO mice exposed to silica.
Evidence does exist that NO attenuates leukocyte adhesion and recruitment into the
lung in certain models of lung inflammation (Gaston et al.,1994;Hickey &
Kubes,1997;Lin et al.,2001;Sato et al.,1999). However, increased infiltration of PMNs in
iNOS KO mice was not observed in this experimental model. It is possible NO-induced
attenuation of PMN recruitment and the equivalent levels of MIP-2 in both mouse types
counteract to result in equivalent BAL yields of PMNs.
Markers of lung injury and blood-air barrier damage, measured as LDH activity
and albumin concentration, respectively, were comparably increased in the WT and
iNOS KO mice 24 hours after silica exposure. By 42 days, these markers were
attenuated in the iNOS KO mice versus the WT but remained elevated above the
respective control. In addition, lung wet weight, at 42 days post-exposure to silica, was
elevated in the WT but not in the iNOS KO. These data suggest that the absence of NO
derived from iNOS appears to exert a beneficial role, in terms of lung injury, which is
more evident in the sub-chronic model than the acute model of silica exposure.
The sub-chronic inflammatory phase was also evaluated via histopathology
(Figure 12 and Table 1). The lung sections and pathology scores noted significant
attenuation of alveolitis and lipoproteinosis, i.e., inflammatory cell infiltration into the
alveoli and increased production of phospholipids and surfactant proteins by alveolar
Type II epithelial cells, respectively, in the iNOS KO versus the WT mice 42 days after
silica exposure. The BAL data showed no differences in cell yields between the WT
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and iNOS KO mice at 42 days post-exposure. As mentioned, BAL recovery of activated
phagocytes is often difficult; therefore, histopathological analysis may be a more
adequate determinant of the extent of the alveolitis. The histopathology data
complemented the other parameters measured that revealed less injury and damage in
the iNOS KO mice in the sub-chronic phase of the response to silica.
Fibrosis was evident histopathologically at 42 day post-silica exposure in the WT
and iNOS KO mice but was not statistically different between the mouse types (data not
shown). TGF-β levels, a mediator involved in the proliferation of fibroblasts and the
subsequent production of extracellular matrix proteins, was also increased by silica
exposure in the two types of mice, but a significant difference between the WT and
iNOS KO was not found. However, whole lung hydroxyproline analysis showed a
statistically significant difference did exist between the WT and iNOS KO mice, the latter
with less fibrosis. Explanations for this conflict may involve assay sensitivity and
animal variability. A limiting factor in the histopathology evaluation is that it is semiquantitative. It also showed a lack of sensitivity for assessing the mouse lung fibrotic
response due to a low experimental n number and high individual variability.
Both animal and human data support a detrimental role for NO in silica-induced
lung injury and disease as mentioned previously (Blackford et al.,1994;Castranova et
al., 1998; Kang et al., 2000;Porter et al.,2002). The present data agrees with those
reported by Porter et al. (2002) which showed that iNOS-derived NO is involved in the
progression of silica-induced lung disease. A mouse silica inhalation study (250 mg/m3,
5 hours/day for 10 days) by Srivastava et al. (2002) also correlates with the present
findings. However, Srivastava and colleagues noted that 1, 6, and 12 weeks after
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exposure, silica did not induce significant pulmonary inflammation in the iNOS KO mice.
These data do not agree with the present report, where marked lung inflammation was
observed at 24 hours that was comparable between the WT and iNOS KO mice and this
inflammation remained elevated above control, but less so in iNOS KO mice, at 42 days
post-exposure. It is likely this may be due to differences such as, exposure dose and
method (aspiration [40 mg/kg] versus inhalation [250 mg/m3]), analysis (BAL parameters
and histopathology versus histopathology alone), and timepoints (24 hours and 42 days
versus 1,6, and 12 weeks) between this study and Srivastava et al. (2002). In general,
however, both studies conclude that absence of iNOS-derived NO reduces the
pulmonary response to silica.
In contrast to the present data, it has been reported that the absence of NO from
iNOS enhances pulmonary inflammation in response to various stimuli. For example,
asbestos instillation in iNOS KO mice resulted in attenuated oxidant-promoted lung
tissue damage but inflammatory parameters, such as TNF-α production and neutrophil
influx, were increased in the iNOS KO versus the WT (Dorger et al.,2002). NO, in acute
lung injury induced by ozone, has been associated with both enhanced damage and
protection in studies using iNOS KO mice (Fakhrzadeh et al.,2002;Kenyon et al.,2002).
Furthermore, hyperoxia-induced acute lung injury is increased in the absence of iNOS
(Kobayashi et al.,2001). Susceptibility to certain microbial pathogens has also been
reported in iNOS KO mice, including respiratory challenge with Bordetella pertussis
(Canthaboo et al.,2002).
In summary, the role of NO in the acute response to silica centered on the
-

oxidant status of the lung. Due to the absence of iNOS, the formation OONO is limited,
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therefore, possibly accounting for the majority of the decreased lung oxidant burden.
The silica-induced lung response in the longer term was less in the iNOS KO mice but
evidence of pulmonary damage, inflammation, and fibrosis was still noted in these
animals. This suggests that NO derived from iNOS contributes to the pathogenesis of
silica-induced lung disease in the mouse model but does not account for all of the lung
pathology. Perhaps, contributions from other inflammatory mediators or reactive
species produced by cells, or silica particles directly account for the injury and damage
still observed in the iNOS KO mice.
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Figure 1- Alveolar macrophage yield per mouse at 24 hours (panel A) and 42 days
(panel B) post-exposure to silica or saline vehicle. a - indicates a significant decrease
from the corresponding control alveolar macrophage yield at 24 hours; b - indicates a
significant difference between the WT and iNOS KO groups (p<0.05).
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Figure 2- Polymorphonuclear leukocyte yield per mouse at 24 hours (panel A) and 42
days (panel B) post-exposure to silica or saline vehicle. a - indicates a significant
increase from the corresponding control polymorphonuclear leukocyte yield (p<0.05).
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Figure 3- First bronchoalveolar lavage fluid lactate dehydrogenase activity at 24 hours
(panel A) and 42 days (panel B) post-exposure to silica or saline vehicle. a - indicates a
significant increase from the corresponding control lactate dehydrogenase activity; b indicates a significant difference between the iNOS KO and WT treated groups
(p<0.05).
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Figure 4- First bronchoalveolar lavage fluid albumin at 24 hours (panel A) and 42 days
(panel B) post-exposure to silica or saline vehicle. a - indicates a significant increase
from the corresponding control albumin levels; b - indicates a significant difference
between the iNOS KO and WT treated groups (p<0.05).
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Figure 5- Lung wet weight at 42 days post-exposure to silica or saline vehicle. a indicates a significant increase from the WT control (p<0.05).
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Figure 6- First bronchoalveolar lavage fluid TNF-α at 24 hours (panel A) and 42 days
(panel B) post-exposure to silica or saline vehicle. a - indicates a significant increase
from the corresponding control TNF-α levels; b - indicates a significant difference
between the iNOS KO and WT treated groups (p<0.05).
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Figure 7- First bronchoalveolar lavage fluid MIP-2 at 24 hours (panel A) and 42 days
(panel B) post-exposure to silica or saline vehicle. a - indicates a significant increase
from the corresponding control MIP-2 levels; *- indicates a significant decrease at 42
days compared to 24 hours post-exposure to silica(p<0.05).
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Figure 8- First bronchoalveolar lavage fluid total antioxidant capacity at 24 hours (panel
A) and 42 days (panel B) post-exposure to silica or saline vehicle. a - indicates a
significant decrease from the corresponding control total antioxidant capacity (p<0.05).
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Figure 9- Zymosan-stimulated alveolar macrophage chemiluminescence at 24 hours
(panel A) and 42 days (panel B) post-exposure to silica or saline vehicle. Data are
presented as percent of control (dashed line represents 100%). a - indicates a
significant increase from the corresponding control zymosan-stimulated
chemiluminescence, b -indicates a significant difference between the iNOS KO and WT
treated groups at 24 hours or 42 days; *- indicates a significant difference between the
24 hours and 42 day AM-CL in the corresponding group (p<0.05).
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Figure 10- First bronchoalveolar lavage fluid TGF-β at 42 days post-exposure to silica
or saline vehicle. a - indicates a significant increase from the corresponding control
TGF-β levels (p<0.05).
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Figure 11- Lung hydroxyproline at 42 days post-exposure to silica or saline vehicle.
Data are presented as percent of control (dashed line represents 100%). a - indicates a
significant increase from the corresponding control; b - indicates a significant difference
between the iNOS KO and WT treated groups (p<0.05).
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Figure 12- Photomicrographs of control (panel A), WT silica-exposed (panel B) and
iNOS KO silica-exposed (panel C) lungs at 42 days post-exposure. Alveolitis (A) and
lipoproteinosis (L) are evident in the silica-exposed lungs as indicated.
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Histopathology Scores at 42 Days Post-Silica Exposure
Control

WT

iNOS KO

Alveolitis

0

4.8 ± 0.3a

2.3 ± 0b

Lipoproteinosis

0

4.7 ± 0.46a

1.9 ± 0b

Table 1- Histopathology scores at 42 days post-silica exposure. Values represent the
sum of the lesion severity and distribution scores and are means ± S.E. (n>3). aindicates a significant difference from the corresponding control; b-indicates a significant
difference between the WT and iNOS KO mice (p<0.05).
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GENERAL DISCUSSION
Occupational lung disease caused by the inhalation of certain inorganic or
organic dusts continues to be an area of avid research. Together the Occupational
Safety and Health Administration (OSHA) and the Centers for Disease Control (CDC),
namely the National Institute for Occupational Safety and Health (NIOSH), strive to
establish strict regulatory controls to limit workplace occurrence of lung diseases, such
as silicosis and other particle-induced pneumoconiosis. Currently, crystalline silica is
considered a human carcinogen and held to an occupational exposure limit, set by
OSHA, of 100 ug/m3. Unfortunately, situations occur in which exposure is unknown or
limits are not strictly enforced resulting in the persistence of this disease into the 21st
century.
Asbestos, a valuable insulating and building material, is a fibrous particulate
associated with multiple lung diseases including cancer. Due to the known adverse
health effects of asbestos, the necessary implementation of novel replacement
materials into the workplace has prompted new areas of research into the possible
health effects of these substitutes. Glass fibers are one example of a man-made
mineral fiber substitute that has been the subject of investigation in the present study as
well as others.
Toxic particles, including silica and asbestos, even at low doses can cause
severe lung responses that involve the chronic activation of lung phagocytic cells and
the recruitment of leukocytes into the alveolar airspace. The lung inflammatory
response attempts to protect the lung initially by removing the particles through innate
defense mechanisms. However, biodurable particles or chronic particle exposure can
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lead to persistent, unresolved inflammation. It is this unresolved phase of the response
that causes further cellular recruitment, mediator production, oxidant generation and
subsequent cellular damage that may cause disregulation of lung repair processes and
proliferation, which could lead to the development of fibrotic lung diseases or even
cancer.
The overall goal of this dissertation was to study lung inflammation and fibrosis
induced by a variety of stimulants. Several models were used to achieve this goal. In
vitro, fibrous particles were used to determine the role of certain particle characteristics
as causative factors in alveolar macrophage (AM) activation and toxicity. In addition,
inducible nitric oxide synthase knockout (iNOS KO) mice were used in the majority of
the studies to further elucidate the role of the reactive species, nitric oxide (NO), in
pulmonary inflammation and fibrosis induced by two different stimuli. Common
parameters, including AM chemiluminescence (CL), inflammatory cytokine and
chemokine production by AMs as well as other pulmonary cell types, and markers of
lung injury and damage, were evaluated in the studies.
Study one of this dissertation was a continuation of other in vitro studies
performed by Blake et al. (1998) and Ye et al. (1999). The present study further
evaluated the role of fiber length versus chemical composition in fiber-induced
cytotoxicity using rat AMs as a model system. Fiber length was a critical factor in
determining the extent of rat AM inflammatory mediator production. Fiber chemical
composition also had effects on cell viability and mediator production, but to a lesser
extent than fiber length. This study also evaluated the cytotoxicity of glass fibers on
human AMs in vitro. In the human AM model system, fiber length below 20 µm did not
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greatly affect toxicity. The difference in the response of rat versus human AMs in the
length dependence of fiber potency is explained by the larger size of the human AM and
points to the importance of frustrated phagocytosis in the pathogenesis of fibrous
particles.
Study two investigated, in vitro, the responses of AMs from iNOS KO or WT mice
to lipopolysaccharide (LPS) or silica. It appeared that, in vitro, changes in basal
reactive species production as well as basal antioxidant status had occurred in AMs
harvested from iNOS KO mice compared to the WT. Once corrected for the differences
.-

in basal production, however, the superoxide (O2 ) and hydrogen peroxide (H2O2)
production in response to in vitro stimuli was equal in the WT and iNOS KO mice. In
addition, the cytokine response was also similar between the WT and iNOS KO mice in
response to LPS ± interferon-γ (IFN-γ), in vitro. This initial experiment allowed the
planning of in vivo studies, taking into account the results of this study as possible
complicating factors in the interpretation of results.
Study three investigated the role of NO in a model of LPS + IFN-γ induced lung
inflammation. This model provided valuable insight into the handling of a nonparticulate inflammatory stimulus that strongly induces the iNOS enzyme and
subsequent production of NO. NO derived from iNOS was anti-inflammatory in this
acute, soluble stimulant inflammatory model with the iNOS KO mice exhibiting a greater
degree of lung inflammation and damage. Furthermore, this study importantly
demonstrated that, in vivo, no changes had occurred in basal reactive species
production or basal total antioxidant capacity. In fact, all parameters investigated
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showed no significant differences between the control states of the iNOS KO and WT
mice.
Study four was prompted from current research in our lab on silica-induced lung
disease in a rat model. Porter and colleagues (2002) demonstrated inhalation of
crystalline silica causes production of NO from iNOS, and this response correlated
temporally and anatomically with the development of lung inflammation and fibrosis in
rats, specifically nitrotyrosine residues and iNOS staining was associated with fibrotic
lesions in the exposed rat lung. The results from the present study agree with those
previously reported (Porter et al.,2002). It was found that NO derived from iNOS was
also a detrimental mediator in a mouse model of silica-induced lung disease, since subchronic lung damage and inflammation in response to silica exposure was depressed in
iNOS KO mice compared to WT mice. Although, NO was found to be an important proinflammatory and pro-fibrotic mediator in the lung response to silica, iNOS KO mice
were not fully protected from the development of this disease.
Lung inflammation and damage caused by fibrous particles is dependent on
dose, dimension, and durability (see literature review). In general, the asbestos
substitute, JM-100 glass fibers was found to activate both human and rat AMs and this
activation was greater with increasing fiber length in the rat but not human AMs for
fibers < 20 µm. Further studies using longer fibers will enable the length question to be
answered fully in human AMs (see discussion – study one). When fiber length was held
constant, different chemical compositions were also found to be a factor in inducing
differential mediator production and cytotoxicity in rat AMs. Although glass fiberinduced cellular activation was observed in vitro, durability in terms of lung clearance,
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fiber translocation, and degradation was not investigated. Durability is a critical
chemical factor in the determination of not only fiber cellular effects but also particles in
general. However, durability can not be evaluated in the short term in vitro studies
described in this dissertation. It might be possible to evaluate the contribution of
durability in long term cultures, using macrophage cell lines. However, technical
problems in maintaining the culture would have to be overcome. Ideally, in vivo studies
using the size-selected fibers would more directly determine how much of a role length
plays in lung pathogenesis. To date, the limited yield of the dielectrophoresis technique
to obtain length-classified fiber samples is the critical technical obstacle.
The iNOS KO mouse was a valuable tool to examine the role of NO in lung
inflammation and fibrosis. Since iNOS is an inducible enzyme, with minimal constitutive
amounts in some pulmonary cells, iNOS gene deletion does not appear to affect the
normal physiologic state of the animal, as they are indistinguishable from the WT
counterpart (Kobzik et al.,1993;Nathan,1997). Initially, however, our in vitro studies with
AMs revealed that the iNOS KO mice may display compensatory mechanisms, but
these changes were not large enough to affect various parameters of lung damage and
inflammation when measured in vivo.
When evaluating the role of NO in pulmonary disease, the iNOS KO mice
exhibited lung responses that were dependent upon the stimulus employed. Increased
inflammation and damage due to acute exposure to LPS + IFN-γ was observed in the
iNOS KO compared to the WT mice. On the other hand, iNOS KO mice were protected
from chronic silica-induced lung effects. The differential responses of the iNOS KO and
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WT mice could be attributed to factors related to the complex nature of the inflammatory
and immune response to these stimuli.
The disparity between the LPS + IFN-γ and silica models could result from the
type of immune response that each stimulus elicits. Studies show that the
differentiation of CD4+ T cells into either T helper 1 or 2 (Th1 or Th2) subsets may
determine the development of interstitial lung disease (Kumar,1989;Rom &
Travis,1992). The differentiation of CD4+ T cells is not fully understood but is known to
be dependent on factors such as the cytokine mileu, dose and type of antigen, and costimulation (Bretscher et al.,1992;Constant et al.,1995;Janeway et al., 1999;Pfeiffer et
al.,1995). Specific cytokines are produced from the T cells that are characteristic of
each type of response. Th1 (cell-mediated immunity) responses are dominated by Th1
cell production of IFN-γ that synergizes with tumor necrosis factor-α (TNF-α) produced
by macrophages (Janeway et al., 1999). This synergy acts to promote macrophage
microbial properties, including production of NO from iNOS and reactive oxygen species
(ROS) (Janeway et al., 1999). In addition, B-lymphocytes produce immunoglobulin (Ig)
G2a (Huaux et al.,1999). Th2 (humoral-immunity) profiles are dominated by Blymphocyte production of IgG1 along with T cell production of interleukins (IL) 4,5,6,10,
and 13 (Huaux et al.,1999; Janeway et al., 1999).
It has been reported that silica-induced lung responses display characteristics of
both Th1 and Th2 type immune responses in rats and certain strains of mice (Garn et
al.,2000;Huaux et al.,1999;van Zijverden et al.,2000;Weissman et al.,2001). Interstitial
lung disease in humans has also been reported to display Th2 responses although a
human study did demonstrate a combination of Th1 and Th2 responses as well (Furuie
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et al.,1997;Walker et al.,1994;Wallace et al.,1995). In response to crystalline silica or
bleomycin, C57BL/6J mice have a tendency toward a predominant Th2 phenotype but
Th1 responses have also been reported (Chung et al.,2003;Huaux et al.,1999;Sharma
et al.,1996). The occurrence of dissimilar immune profiles may depend upon the
dominant overall immune response of the mouse or other complicating factors. For
example, the background mouse strain in the present study (C57BL/6J) is
predominantly a Th1 responder but, as mentioned above, do not always display this
profile in response to silica. This may be due to the type of silica and dosage used
because these factors also determine the subsequent immune response.
The specific immune response elicited by a combination of LPS + IFN-γ has not
been described. Although LPS, due to its bacterial origin, has been shown to be a Th1
mediated pulmonary response that typically fails to progress into a fibrotic state
(Rylander et al.,1987). Presumably, the addition of IFN-γ may elicit a Th1 response due
to its involvement in the response itself and its inhibitory effects on proliferation of Th2
cells (Janeway et al., 1999). Therefore, it appeared that iNOS derived NO, assumed
different roles depending on the immune response elicited by each stimulus and this
was dependent on the origin (i.e. bacterial or non-bacterial). It is also important to note
that the short-term responses revealed minimal differences between the two types of
mice and this may be due to the length of time needed to integrate signals and mount
an appropriate immune response.
The lung response to particles, such as crystalline silica, compared to bacterial
products (i.e. LPS) is not comparable. In the absence of iNOS derived NO, the lung
response induced by silica is attenuated. However, it is augmented in response to LPS
176

+ IFN-γ. Consideration must be given to the stimulus itself as another factor involved in
the differential responses. Crystalline silica, is an inorganic, biopersistent, reactive
particle that acts primarily through the phagocyte scavenger receptor (Iyer et
al.,1996;Kobzik,1995). When significant exposure occurs, this particle can cause lung
fibrosis and/or cancer (Altree-Williams & Clapp,2002;Erdogdu & Hasirci,1998). The
surface of the silica particle is responsible for the production of various reactive species
and also displays a negative surface charge as well as silanol groups that are known to
be involved in alveolar macrophage toxicity (Bagchi,1992;Ghio et al.,1990;Shi et
al.,1989;Wiessner et al.,1990). This inherent toxicity of the silica particle alone
contributes to pulmonary inflammation and damage. Eventhough it is evident that iNOS
is involved in many aspects of silica-induced lung disease, it appears not to be the initial
determinant of the pulmonary effects. The unique reactivity of the silica particle must
also contribute to the detrimental effects.
The bacterial derivative LPS, which signals through the toll-like receptor on
phagocytes, and the inflammatory cytokine IFN-γ are factors involved in initiating a
potent inflammatory response in mice. As mentioned, iNOS KO mice were subject to
greater overall lung inflammation and damage than the WT mice 72 hours postexposure to LPS + IFN-γ. Perhaps NO from iNOS, in this case, serves to down regulate
toll-like receptor induced signaling pathways [particularly nuclear factor-κB (NF-κB)],
thus, ending the inflammatory cycle. Indeed, it has been suggested that,
downregulation of NF-κB by exogenous NO serves to attenuate neutrophil influx,
reactive oxygen species activity, and lung injury in animal models of LPS-induced acute
lung injury (ALI) (Bloomfield et al.,1997;Kang et al.,2002). In contrast, exogenous NO
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has been shown to upregulate NF-κB activation in silica treated macrophages (Kang et
al.,2000). A sub-chronic LPS + IFN-γ exposure model would aid in determining whether
the lack of iNOS would eventually contribute to pathogenic effects in these animals.
Thus, the importance and role of iNOS derived NO during a presumably Th1 dominated
inflammatory state would be further elucidated.
Taken together, these studies demonstrate that iNOS derived NO is beneficial in
certain circumstances and detrimental in others. Whether it would be advantageous to
inhibit iNOS chronically is debatable. Without iNOS, susceptibility to infection may
occur but in regards to the extent of particle-induced pulmonary inflammation and
fibrosis its absence is clearly beneficial.
In summary, pulmonary inflammation and the development of fibrosis is a
complicated matter. The present set of studies were designed to contribute to the
further understanding of mechanisms and signals that may be involved in the
inflammatory process and the progression of lung disease. In general, inflammation is
not a simple response. Stimulus-dependent responses can occur and the response of
different species to each stimulus may also vary. Fibrous particles induce inflammatory
reactions that differ from those of spherical particles or even bacterial products.
Although common mediators are involved in each case, the particular role of each
mediator may vary with time and/or experimental setting.
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